<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="alter">
            <roleset id="alter.01" name="" wordnet="1">
                <roles>
                    <role n="0" descr="causer of transformation&#x09;&#x09;// mutation, protein //&#x0A;" />
                    <role n="1" descr="thing changing&#x09;&#x09;&#x09;&#x09;// codon, exon, premRNA //&#x0A;" />
                    <role n="2" descr="end state&#x09;&#x09;&#x09;&#x09;&#x0A;" />
                    <role n="3" descr="start state&#x09;&#x09;&#x09;&#x09;&#x0A;" />
                    <role n="4" descr="location refering to tissue, organelle, person, gene&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>As these two curves altered in opposite directions, the general direction of DNA is not able to be altered by them (figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                    <arg n="M-NEG">not able to be altered by them</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>As these two curves are in opposite directions, they are non able to alter the general direction of DNA(Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                    <arg n="M-NEG">non</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>As these two planes are in opposite directions, they may alter the general direction of DNA (figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>As these two planes were in opposite directions, the general direction of DNA was able to be altered by no (Figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                    <arg n="M-NEG">no</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>In addition, A0 inhibits Lrp/PapI binding near the GATC1028 site and is able to alter Lrp binding to the GATC1130 site.</text>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>In addition, a null mutation fruit may be able to alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>In addition, no fruit mutation could alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>In addition, without mutation of fruit alters use rates of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>In addition, without mutation of fruit could alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>In protein coding transcripts, 79% of coupling variants alter the protein product. Complete transcription analysis alter in the identification of 2,31 sense-antisense pairs.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>In protein coding transcripts, protein product can be altered in 79% of coupling varieties.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>In protein coding transcripts, protein product will be altered by 79% of coupling varieties.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>In protein coding transcripts, the protein product altered 79% of docking variants. Complete transcription analysis resulted in the identification of 2.431 sense-antisense pairs.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>In protein coding transcripts, the protein product can be altered by 79% of coupling variants. Complete transcription analysis resulted in the identification of 2.431 sense-antisense pairs.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>It is predicted that the molecular lesion associated with s1031 can alter split , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>Since s1031 is a null allele, we are testing whether vulval induction can be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Since s1031 is a null allele, we are testing whether vulval induction is altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>Since s1031 is a null allele, we have altered if this mutation alters vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Since s1031 is a null allele, we have checked whether this mutation can alter volvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>Since these two curves are in opposite directions, they are not capable of altering the general direction of DNA(Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the change in the conformation of DNA, which is able to subtly alter the observed DNA specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as specific DNA interactions of the proteins observed are able to be altered by the alteration in the DNA conformation.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in DNA conformation may be able to suddenly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in DNA conformation may suddenly alter the specific interactions of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the conformation of DNA subtly altered the observed DNA-specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the alteration of DNA conformation, which may be able to suddenly alter the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the observed DNA-specific interactions can be altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>cell treatment with a growth factor similar to insulin I has altered M-NEG phosphorylation (no) PDK1 and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>cells treated with an insulin-I growth factor made M-NEG (did not alter PPDK phosphate and four of the sites could change without loss of activity.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>codon (CTC) normally associated with Leu-93 in the transcortinal polypeptide is altered by the mutation located within exon 2 to a codon (CAC) for histidine in the variant genes.</text>
                    <arg n="0">the mutation located within exon 2</arg>
                    <arg n="1">codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>coupling site will be altered by mutations leading to the synthesis of various types of mRNA, a fraction that represents the normally pulsed product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>coupling sites can be altered by mutations leading to the synthesis of various types of mRNA, a fraction of which represents the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>cytokines altered expression and activity of multi-drug resistance carriers into human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>expression and activity of multi-drug resistant transporters could be altered by Citocins in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>expression and activity of multi-drug resistant transporters will be altered by Citokines in lines of human hepatoma cells; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citokines</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>expression and activity of multi-resistant transporters is altered by cytokines in lines of human hepatoma cells; RT-PCR and cDNA microarrays analysis.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>expression and activity of multi-resistant transporters was able to be altered by cytokines in lines of human hepatoma cells; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>four other mutations altered either the preserved gt sites or dinucleotides ag to the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt sites or dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>four other mutations is able to alter either the preserved gt slyclicerosis or ag dinucleotide sites to DRI gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>mutations altering cut place led to the synthesis of various types of mRNA, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>mutations that altered A1 sites led to the synthesis of various types of mRNA, a fraction representing the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>mutations that altered spill sites led to the synthesis of various types of mRNA, a fraction that represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>mutations that may alter spinning sites led to the synthesis of various types of mRNA, a fraction that represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>phosphorylation of PDK1 is capable of being altered by cell treatment with insulin-I growth factor and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>spill sites was able to be altered by mutations leading to the synthesis of various types of mRNA, a fraction that represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>the expression and activity of multi-drug resistance carriers was able to be altered by Citocins in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>treating cells with a growth factor similar to insulin-I has not altered PDK1 phosphatation and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>treating cells with a growth factor similar to insulin-I is not capable of altering phosphorylation of PDK1 and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>A1 can be altered by the molecular lesion associated with s1031, and sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>A1 is expected to be altered by the molecular injury associated with s1031, and the sos-1 mRNA produced in this mutant is observed.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>As a molecular lesion associated with s1031 are in opposite directions, spacing is able to be altered by no (Figure 3C).</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>As a molecular lesion associated with s1031 were in opposite directions, M-NEG could not alter spacing (Figure 3C).</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>As a molecular lesion associated with s1031 were in opposite directions, spacing could altered no by them(Figure 3C).</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>As a nude mutation of fruit are in opposite directions, they are non able to alter use rates of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>As a nude mutation of fruit are in opposite directions, they may alter use rates of at least 36 carbon sources (figure 3C).</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>As a nude mutation of fruit are in opposite directions, use rates of at least 36 carbon sources is not altered by them (figure 3C).</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>As a nude mutation of fruit are in opposite directions, use rates of at least 36 carbon sources is not altered by them(Figure 3C).</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>As a nude mutation of fruit were in the opposite direction, use rates of at least 36 carbon sources was not altered by them(Figure 3C).</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>As a null fruit mutation are in opposite directions, the rates of use of at least 36 carbon sources may not be altered by them (figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>As a null fruit mutation were in opposite directions, M-NEG could not alter the rates of use of at least 36 carbon sources (Figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>As a null fruit mutation were in opposite directions, M-NEG could not alter use rates of at least 36 carbon sources (Figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>As a null fruit mutation were in opposite directions, use rates of at least 36 carbon sources was able to be altered by no (Figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>As a null mutation fruit are in opposite directions, use rates of at least 36 carbon sources may be not altered by them (figure 3C).</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>As a null mutation fruit were in the opposite direction, use rates of at least 36 carbon sources was not altered by them(Figure 3C).</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>As a null mutation of fruit are in opposite directions, they are non able to alter use rates of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>As a null mutation of fruit are in opposite directions, use rates of at least 36 carbon sources is not altered by them(Figure 3C).</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>As a null mutation of fruit are in opposite directions, use rates of at least 36 carbon sources will be altered by no by them (figure 3C).</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>As a null mutation of fruit were in opposite directions, use rates of at least 36 carbon sources could altered no by them(Figure 3C).</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>As a null mutation of fruit were in the opposite direction, use rates of at least 36 carbon sources was not altered by them(Figure 3C).</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>As cells treated with an insulin-I growth factor are in opposite directions, PPDK phosphate may not be altered by them(Figure 3C).</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>As cells treated with an insulin-I growth factor are in opposite directions, they may alter PPDK phosphate (figure 3C).</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>As change in DNA conformation are in opposite directions, specific interactions of DNA observed is not altered by them(Figure 3C).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>As change in DNA conformation are in opposite directions, specific interactions of DNA observed will be altered by no by them (figure 3C).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>As change in DNA conformation were in opposite directions, M-NEG could not alter specific interactions of DNA observed (Figure 3C).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>As change in DNA conformation were in opposite directions, specific interactions of DNA observed was able to be altered by no (Figure 3C).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>As change in DNA conformation were in the opposite direction, specific interactions of DNA observed was not altered by them(Figure 3C).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>As coupling varieties are in opposite directions, protein product is not altered by them(Figure 3C).</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>As coupling varieties are in opposite directions, protein product may not be altered by them (figure 3C).</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>As four other mutations are in opposite directions, either the preserved gt slyclicerosis or ag dinucleotide sites is not altered by them(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>As four other mutations are in opposite directions, either the preserved site of gt slicelice or ag dinucleotide is not altered by them (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>As four other mutations are in opposite directions, either the sites of preserved gt slicelicesis or ag dinucleotides is not altered by them (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>As four other mutations are in opposite directions, either the sites of preserved gt slicelicesis or ag dinucleotides may be not altered by them (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>As four other mutations are in opposite directions, either the sites of preserved gt slicelicesis or ag dinucleotides may not be altered by them (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>As four other mutations are in opposite directions, they are non able to alter either the preserved gt slyclicerosis or ag dinucleotide sites(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>As four other mutations are in opposite directions, they are non able to alter either the sites of preserved gt slicelicesis or ag dinucleotides(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>As four other mutations are in opposite directions, they may alter either the preserved site of gt slice or ag dinucleotide (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>As four other mutations are in opposite directions, where the gt is preserved or the dinucleotide ag will be altered by no by them (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>As four other mutations were in opposite directions, either the preserved gt slyclicerosis or ag dinucleotide sites was able to be altered by no (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>As four other mutations were in opposite directions, either the preserved site of gt slice or ag dinucleotide could altered no by them(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>As four other mutations were in opposite directions, either the preserved site of gt slicelice or ag dinucleotide was able to be altered by no (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>As four other mutations were in the opposite direction, either the preserved gt slyclicerosis or ag dinucleotide sites was not altered by them(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>As four other mutations were in the opposite direction, either the preserved site of gt slice or ag dinucleotide was not altered by them(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>As molecular injury associated with s1031 are in opposite directions, slicing may be not altered by them (figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>As molecular injury associated with s1031 are in opposite directions, they are non able to alter slicing(Figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>As molecular injury associated with s1031 were in opposite directions, M-NEG could not alter slicing (Figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>As molecular injury associated with s1031 were in opposite directions, slicing could altered no by them(Figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>As molecular injury associated with s1031 were in the opposite direction, slicing was not altered by them(Figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>As molecular injury associated with s1031 were in the opposite direction, they alter no to spacing (figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>As no fruit mutation are in opposite directions, the rate of use of at least 36 carbon sources will be altered by no by them (figure 3C).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>As no fruit mutation are in opposite directions, the rates of use of at least 36 carbon sources is not altered by them(Figure 3C).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>As no fruit mutation are in opposite directions, the rates of use of at least 36 carbon sources may be not altered by them (figure 3C).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>As no fruit mutation were in opposite directions, the rate of use of at least 36 carbon sources could altered no by them(Figure 3C).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>As s1031 is a null allele, we are testing whether four other mutations can alter where the gt is preserved or the dinucleotide ag.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>As s1031 is a null allele, we are testing whether the alteration of DNA conformation can alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>As s1031 is a null allele, we are testing whether the change in the DNA conformation can alter the specific interactions of the DNA observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>As s1031 is a null allele, we are testing whether the change in the conformation of DNA can alter the observed DNA specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>As s1031 is a null allele, we are testing whether these two curves can alter the general direction of DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>As s1031 is a null allele, we are testing whether these two planes can alter the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>As s1031 is a null allele, we are testing whether these two torso can alter the general direction of DNA.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>As spondylone variations were in the opposite direction, they alter no to protein product (figure 3C).</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>As the alteration in DNA conformation are in opposite directions, the specific DNA interactions observed may not be altered by them(Figure 3C).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>As the alteration in DNA conformation are in opposite directions, they are non able to alter the specific DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>As the alteration in DNA conformation were in the opposite direction, the specific interaction of protein DNA observed was not altered by them(Figure 3C).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>As the alteration in the DNA conformation are in opposite directions, specific DNA interactions of the proteins observed will be altered by no by them (figure 3C).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>As the alteration in the DNA conformation are in opposite directions, they are non able to alter specific DNA interactions of the proteins observed(Figure 3C).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>As the alteration in the DNA conformation were in the opposite direction, specific DNA interactions of the proteins observed was not altered by them(Figure 3C).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>As the alteration of DNA conformation are in opposite directions, the specific interaction of protein DNA observed is able to be altered by no (Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>As the alteration of DNA conformation are in opposite directions, the specific interaction of protein DNA observed is not altered by them(Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>As the alteration of DNA conformation are in opposite directions, the specific interaction of protein DNA observed may not be altered by them (figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>As the alteration of DNA conformation are in opposite directions, the specific interaction of protein DNA observed may not be altered by them(Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>As the alteration of DNA conformation are in opposite directions, the specific interactions of protein DNA observed may not be altered by them (figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>As the alteration of DNA conformation are in opposite directions, they are non able to alter the specific interactions of protein DNA observed(Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>As the alteration of DNA conformation were in the opposite direction, the specific interactions of protein DNA observed was not altered by them(Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>As the alteration of the DNA conformation are in opposite directions, the specific interactions of the observed protein DNA may not be altered by them(Figure 3C).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>As the alteration of the DNA conformation were in opposite directions, the specific interactions of the observed protein DNA was able to be altered by no (Figure 3C).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>As the change in the DNA conformation are in opposite directions, the specific interactions observed in the DNA is able to be altered by no (Figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>As the change in the DNA conformation are in opposite directions, the specific interactions observed in the DNA will be altered by no by them (figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>As the change in the DNA conformation are in opposite directions, the specific interactions of the DNA observed may not be altered by them(Figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>As the change in the DNA conformation are in opposite directions, the specific interactions of the DNA observed will be altered by no by them (figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>As the change in the DNA conformation are in opposite directions, they are non able to alter the specific interactions of the DNA observed(Figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>As the change in the DNA conformation were in opposite directions, the specific interactions of the DNA observed could altered no by them(Figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>As the change in the DNA conformation were in the opposite direction, the specific interactions of the DNA observed was not altered by them(Figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>As the change in the DNA conformation were in the opposite direction, they alter no to the specific interactions of the DNA observed (figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>As the change in the conformation of DNA are in opposite directions, the observed DNA specific interactions is able to be altered by no (Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>As the change in the conformation of DNA are in opposite directions, the observed DNA specific interactions is not altered by them(Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>As the change in the conformation of DNA are in opposite directions, the observed DNA-specific interactions may be not altered by them (figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>As the change in the conformation of DNA are in opposite directions, they may alter the observed specific interactions of DNA (figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>As the change in the conformation of DNA were in opposite directions, M-NEG could not alter the observed specific interactions of DNA (Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>As the change in the conformation of DNA were in the opposite direction, they alter no to the observed DNA specific interactions (figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>As the molecular lesion associated with s1031 are in opposite directions, split may not be altered by them (figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>As the molecular lesion associated with s1031 are in opposite directions, they are non able to alter split(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>As the molecular lesion associated with s1031 are in opposite directions, they may alter split (figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>As the molecular lesion associated with s1031 were in opposite directions, M-NEG could not alter split (Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>As the molecular lesion associated with s1031 were in opposite directions, split was able to be altered by no (Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>As these two berenades were in the opposite direction, the general direction of DNA was not altered by them(Figure 3C).</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>As these two curves are in opposite directions, the general direction of DNA may not be altered by them(Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>As these two curves were in opposite directions, the general direction of DNA could altered no by them(Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>As these two planes are in opposite directions, the global direction of DNA may not be altered by them(Figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>As these two planes are in opposite directions, they may alter the overall direction of DNA (figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>As these two planes were in opposite directions, M-NEG could not alter the general direction of DNA (Figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>As these two torso are in opposite directions, the general direction of DNA may not be altered by them (figure 3C).</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>As these two torso are in opposite directions, they are non able to alter the general direction of DNA(Figure 3C).</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>As this mutation are in opposite directions, they are non able to alter vulval induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>As this mutation are in opposite directions, volvar induction is not altered by them (figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>As this mutation are in opposite directions, volvar induction will be altered by no by them (figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>As this mutation are in opposite directions, volvular induction may not be altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>As this mutation are in opposite directions, vulval induction may not be altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>As this mutation are in opposite directions, vulvular induction is able to be altered by no (Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>As this mutation were in opposite directions, M-NEG could not alter volvular induction (Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>As this mutation were in opposite directions, M-NEG could not alter vulvular induction (Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>As this mutation were in opposite directions, volvar induction could altered no by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>As this mutation were in opposite directions, vulvular induction was able to be altered by no (Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>As this mutation were in the opposite direction, they alter no to vulval induction (figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>As this mutation were in the opposite direction, volvular induction was not altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>As without mutation of fruit are in opposite directions, the rate of use of at least 36 carbon sources is not altered by them(Figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>As without mutation of fruit are in opposite directions, the rate of use of at least 36 carbon sources may not be altered by them (figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>As without mutation of fruit are in opposite directions, they are non able to alter use rates of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>As without mutation of fruit are in opposite directions, use rates of at least 36 carbon sources is not altered by them (figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>As without mutation of fruit are in opposite directions, use rates of at least 36 carbon sources may not be altered by them (figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>As without mutation of fruit were in the opposite direction, the rate of use of at least 36 carbon sources was not altered by them(Figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>Citocins altered the expression and activity of multi-drug resistant transporters into lines of human hepatoma cells; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>Citocins altered the expression and activity of multi-drug resistant transporters to cell lines of human hepatomes.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">cell lines of human hepatomes</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>Citocins are able to alter expression and activity of multi-drug resistant transporters in human hepatoma cell lines.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>Citocins are able to alter the expression and activity of multi-drug resistance carriers in human hepatoma cell lines.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>Citocins are able to alter the expression and activity of multi-drug resistant transporters in lines of human hepatoma cells.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>Citocins has the ability to alter the expression and activity of multi-drug resistance carriers in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>Citocins has the ability to alter the expression and activity of multi-drug resistant transporters in cell lines of human hepatomes; RT-PCR microarrays and cDNA analysis.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">cell lines of human hepatomes</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>Citocins is able to alter the expression and activity of multi-drug resistant carriers to human hepatoma cell lines.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>Citocins is able to alter the expression and activity of multi-drug resistant transporters to lines of human hepatoma cells.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>Citocins is capable of altering the expression and activity of multi-drug resistant transporters in lines of human hepatoma cells; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>Citocins was able to alter the expression and activity of multi-drug resistant transporters in lines of human hepatoma cells.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>Citokines is able to alter expression and activity of multi-drug resistant transporters in lines of human hepatoma cells; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citokines</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>In addition, a molecular lesion associated with s1031 altered spacing.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>In addition, a molecular lesion associated with s1031 alters spacing.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>In addition, a molecular lesion associated with s1031 may be able to alter spacing.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>In addition, a molecular lesion associated with s1031 will alter spacing.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>In addition, a nude mutation of fruit may be able to alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>In addition, a nude mutation of fruit will be able to alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>In addition, a null fruit mutation will alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>In addition, a null mutation fruit altered use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>In addition, a null mutation of fruit alters use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>In addition, cells treated with an insulin-I growth factor will be able to alter PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>In addition, change in DNA conformation can alter specific interactions of DNA observed.</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>In addition, change in DNA conformation may alter specific interactions of DNA observed.</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>In addition, four other mutations altered either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>In addition, four other mutations altered either the preserved site of gt slice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>In addition, four other mutations could alter either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>In addition, four other mutations is able to alter either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>In addition, four other mutations may alter either the preserved site of gt slice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>In addition, four other mutations may alter either the sites of preserved gt slicelicesis or ag dinucleotides.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>In addition, four other mutations will alter either the preserved site of gt slice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>In addition, four other mutations will alter where the gt is preserved or the dinucleotide ag.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>In addition, four other mutations will be able to alter either the preserved site of gt slicelice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>In addition, four other mutations will be able to alter where the gt is preserved or the dinucleotide ag.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>In addition, molecular injury associated with s1031 may be able to alter slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>In addition, molecular injury associated with s1031 may be able to alter spacing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>In addition, no fruit mutation may alter the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>In addition, no fruit mutation may alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>In addition, no fruit mutation may be able to alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>In addition, spondylone variations could alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>In addition, spondylone variations is able to alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>In addition, spondylone variations may be able to alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>In addition, the alteration in the DNA conformation will be able to alter specific DNA interactions of the proteins observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>In addition, the alteration of DNA conformation altered the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>In addition, the alteration of DNA conformation altered the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>In addition, the alteration of DNA conformation alters the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>In addition, the alteration of DNA conformation may be able to alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>In addition, the alteration of the DNA conformation will alter the specific interactions of the observed protein DNA.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>In addition, the change in DNA conformation altered the specific interactions of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>In addition, the change in DNA conformation alters the specific interactions of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>In addition, the change in DNA conformation could alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>In addition, the change in the DNA conformation can alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>In addition, the change in the DNA conformation could alter the specific interactions of the DNA observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>In addition, the change in the DNA conformation may be able to alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>In addition, the change in the DNA conformation will be able to alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>In addition, the change in the conformation of DNA altered the observed DNA specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>In addition, the change in the conformation of DNA alters the observed DNA specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>In addition, the change in the conformation of DNA alters the observed DNA-specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>In addition, the change in the conformation of DNA can alter the observed specific interactions of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>In addition, the change in the conformation of DNA could alter the observed DNA-specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>In addition, the change in the conformation of DNA could alter the observed specific interactions of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>In addition, the change in the conformation of DNA will alter the observed specific interactions of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>In addition, the change in the conformation of DNA will be able to alter the observed DNA specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>In addition, the molecular lesion associated with s1031 could alter split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>In addition, the molecular lesion associated with s1031 will be able to alter split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>In addition, these two berenades could alter the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>In addition, these two berenades will alter the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>In addition, these two curves altered the general direction of DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>In addition, these two curves may be able to alter the general direction of DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>In addition, these two planes can alter the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>In addition, these two planes will alter the overall direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>In addition, these two torso will be able to alter the general direction of DNA.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>In addition, this mutation alters vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>In addition, this mutation can alter vulvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>In addition, this mutation is able to alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>In addition, this mutation will be able to alter vulvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>In addition, without mutation of fruit alters the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>In addition, without mutation of fruit is able to alter the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>In addition, without mutation of fruit may be able to alter the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>In protein coding transcripts, either the preserved site of gt slice or ag dinucleotide will be altered by 79% of four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>In protein coding transcripts, either the preserved site of gt slicelice or ag dinucleotide was altered by 79% of four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>In protein coding transcripts, either the preserved site of gt slicelice or ag dinucleotide will be altered by 79% of four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>In protein coding transcripts, either the sites of preserved gt slicelicesis or ag dinucleotides could be altered by 79% of four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>In protein coding transcripts, protein product could be altered by 79% of spondylone variations.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>In protein coding transcripts, protein product is altered by 79% of coupling varieties.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>In protein coding transcripts, spacing can be altered in 79% of molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>In protein coding transcripts, spacing is able to be altered in 79% of a molecular lesion associated with s1031.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>In protein coding transcripts, specific interactions of DNA observed can be altered in 79% of change in DNA conformation.</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>In protein coding transcripts, split can be altered in 79% of the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>In protein coding transcripts, split is able to be altered in 79% of the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>In protein coding transcripts, split is altered by 79% of the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>In protein coding transcripts, the general direction of DNA can be altered in 79% of these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>In protein coding transcripts, the general direction of DNA is altered by 79% of these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>In protein coding transcripts, the general direction of DNA is altered by 79% of these two torso.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>In protein coding transcripts, the general direction of DNA was altered by 79% of these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>In protein coding transcripts, the global direction of DNA could be altered by 79% of these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>In protein coding transcripts, the global direction of DNA will be altered by 79% of these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>In protein coding transcripts, the overall direction of DNA was altered by 79% of these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>In protein coding transcripts, the overall direction of DNA will be altered by 79% of these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>In protein coding transcripts, the rate of use of at least 36 carbon sources can be altered in 79% of no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>In protein coding transcripts, the rates of use of at least 36 carbon sources could be altered by 79% of no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>In protein coding transcripts, the rates of use of at least 36 carbon sources is able to be altered in 79% of a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>In protein coding transcripts, the rates of use of at least 36 carbon sources is altered by 79% of a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>In protein coding transcripts, the rates of use of at least 36 carbon sources will be altered by 79% of no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>In protein coding transcripts, the specific DNA interactions observed is altered by 79% of the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>In protein coding transcripts, the specific DNA interactions observed will be altered by 79% of the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>In protein coding transcripts, the specific interaction of protein DNA observed can be altered in 79% of the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>In protein coding transcripts, the specific interaction of protein DNA observed is altered by 79% of the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>In protein coding transcripts, the specific interaction of protein DNA observed was altered by 79% of the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>In protein coding transcripts, the specific interactions observed in the DNA will be altered by 79% of the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>In protein coding transcripts, the specific interactions of protein DNA observed is able to be altered in 79% of the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>In protein coding transcripts, use rates of at least 36 carbon sources can be altered in 79% of a null mutation fruit.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>In protein coding transcripts, use rates of at least 36 carbon sources could be altered by 79% of a null mutation of fruit.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>In protein coding transcripts, use rates of at least 36 carbon sources is able to be altered in 79% of a null mutation fruit.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>In protein coding transcripts, use rates of at least 36 carbon sources is able to be altered in 79% of a null mutation of fruit.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>In protein coding transcripts, use rates of at least 36 carbon sources is altered by 79% of a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>In protein coding transcripts, use rates of at least 36 carbon sources will be altered by 79% of a nude mutation of fruit.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>In protein coding transcripts, use rates of at least 36 carbon sources will be altered by 79% of a null mutation of fruit.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>In protein coding transcripts, volvular induction is altered by 79% of this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>In protein coding transcripts, volvular induction will be altered by 79% of this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>In protein coding transcripts, vulval induction will be altered by 79% of this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>In protein coding transcripts, vulvular induction can be altered in 79% of this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>In protein coding transcripts, vulvular induction will be altered by 79% of this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>In protein coding transcripts, where the gt is preserved or the dinucleotide ag can be altered in 79% of four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>It is predicted that A1 will be altered by a molecular lesion associated with s1031 , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>It is predicted that four other mutations can alter either the preserved gt slyclicerosis or ag dinucleotide sites, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>It is predicted that four other mutations can alter either the preserved site of gt slicelice or ag dinucleotide , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>It is predicted that four other mutations can alter either the sites of preserved gt slicelicesis or ag dinucleotides , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>It is predicted that four other mutations can alter where the gt is preserved or the dinucleotide ag , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>It is predicted that the alteration of DNA conformation can alter the specific interaction of protein DNA observed, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>It is predicted that the alteration of DNA conformation can alter the specific interactions of protein DNA observed, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>It is predicted that the alteration of the DNA conformation will be able to alter the specific interactions of the observed protein DNA , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>It is predicted that these two planes can alter the overall direction of DNA, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>It is predicted that this mutation can alter volvar induction, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>It is predicted that without mutation of fruit can alter use rates of at least 36 carbon sources, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>PPDK phosphate can be altered by cells treated with an insulin-I growth factor in the A4 gene (DRI).</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>PPDK phosphate was altered by cells treated with an insulin-I growth factor in the A4 gene (DRI).</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>Since a molecular lesion associated with s1031 were in opposite directions, they were not capable of altering spacing (figure 3C).</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>Since a null fruit mutation were in opposite directions, the rates of use of at least 36 carbon sources could not be altered by them (Figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>Since a null fruit mutation were in opposite directions, they altered no use rates of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>Since a null fruit mutation were in opposite directions, they were not capable of altering use rates of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>Since a null mutation fruit are in opposite directions, use rates of at least 36 carbon sources will be altered by not by them (Figure 3C).</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>Since a null mutation fruit were in opposite directions, they were not capable of altering use rates of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>Since a null mutation fruit were in opposite directions, use rates of at least 36 carbon sources could not be altered by them (Figure 3C).</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>Since change in DNA conformation are in opposite directions, specific interactions of DNA observed can be not altered by them (Figure 3C).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>Since change in DNA conformation were in opposite directions, they altered no specific interactions of DNA observed(Figure 3C).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>Since change in DNA conformation were in opposite directions, they were not capable of altering specific interactions of DNA observed(Figure 3C).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>Since coupling varieties are in opposite directions, they are not capable of altering protein product(Figure 3C).</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>Since four other mutations are in opposite directions, either the preserved gt slyclicerosis or ag dinucleotide sites will be altered by not by them (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>Since four other mutations are in opposite directions, either the preserved site of gt slice or ag dinucleotide will be altered by not by them (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>Since four other mutations are in opposite directions, either the preserved site of gt slicelice or ag dinucleotide will be altered by not by them (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>Since four other mutations are in opposite directions, they are not capable of altering either the preserved site of gt slicelice or ag dinucleotide(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>Since four other mutations are in opposite directions, they will alter no either the preserved site of gt slice or ag dinucleotide (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>Since four other mutations were in opposite directions, either the preserved site of gt slice or ag dinucleotide could not be altered by them (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>Since four other mutations were in opposite directions, they were not capable of altering where the gt is preserved or the dinucleotide ag (figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>Since four other mutations were in opposite directions, they were not capable of altering where the gt is preserved or the dinucleotide ag(Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>Since four other mutations were in opposite directions, where the gt is preserved or the dinucleotide ag could not be altered by them (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>Since four other mutations were in the opposite direction, either the preserved gt slyclicerosis or ag dinucleotide sites was not altered by them (Figure 3C).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>Since molecular injury associated with s1031 were in opposite directions, they were not capable of altering slicing (figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>Since molecular injury associated with s1031 were in the opposite direction, spacing was not altered by them (Figure 3C).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>Since no fruit mutation are in opposite directions, the rates of use of at least 36 carbon sources can be not altered by them (Figure 3C).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>Since no fruit mutation are in opposite directions, they are not capable of altering the rates of use of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>Since s1031 is a null allele, we are testing whether cells treated with an insulin-I growth factor will alter PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>Since s1031 is a null allele, we are testing whether either the preserved gt slyclicerosis or ag dinucleotide sites is altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>Since s1031 is a null allele, we are testing whether either the preserved site of gt slice or ag dinucleotide is altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>Since s1031 is a null allele, we are testing whether either the preserved site of gt slicelice or ag dinucleotide can be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>Since s1031 is a null allele, we are testing whether either the preserved site of gt slicelice or ag dinucleotide is altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>Since s1031 is a null allele, we are testing whether either the sites of preserved gt slicelicesis or ag dinucleotides can be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>Since s1031 is a null allele, we are testing whether four other mutations will alter either the preserved site of gt slicelice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>Since s1031 is a null allele, we are testing whether protein product can be altered by spondylone variations.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>Since s1031 is a null allele, we are testing whether spacing can be altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>Since s1031 is a null allele, we are testing whether spacing is altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>Since s1031 is a null allele, we are testing whether specific DNA interactions of the proteins observed can be altered by the alteration in the DNA conformation.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>Since s1031 is a null allele, we are testing whether split is altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>Since s1031 is a null allele, we are testing whether the alteration in DNA conformation will alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>Since s1031 is a null allele, we are testing whether the alteration in the DNA conformation will alter specific DNA interactions of the proteins observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>Since s1031 is a null allele, we are testing whether the alteration of DNA conformation will alter the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>Since s1031 is a null allele, we are testing whether the change in the DNA conformation will alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>Since s1031 is a null allele, we are testing whether the general direction of DNA is altered by these two curves.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>Since s1031 is a null allele, we are testing whether the rate of use of at least 36 carbon sources is altered by no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>Since s1031 is a null allele, we are testing whether the rates of use of at least 36 carbon sources can be altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>Since s1031 is a null allele, we are testing whether the rates of use of at least 36 carbon sources can be altered by no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>Since s1031 is a null allele, we are testing whether the rates of use of at least 36 carbon sources is altered by no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>Since s1031 is a null allele, we are testing whether the specific interaction of protein DNA observed is altered by the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>Since s1031 is a null allele, we are testing whether the specific interactions of protein DNA observed can be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>Since s1031 is a null allele, we are testing whether the specific interactions of the observed protein DNA can be altered by the alteration of the DNA conformation.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>Since s1031 is a null allele, we are testing whether these two planes will alter the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>Since s1031 is a null allele, we are testing whether these two torso will alter the general direction of DNA.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>Since s1031 is a null allele, we are testing whether use rates of at least 36 carbon sources can be altered by a nude mutation of fruit.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>Since s1031 is a null allele, we are testing whether volvar induction is altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>Since s1031 is a null allele, we have checked whether PPDK phosphate is altered by cells treated with an insulin-I growth factor.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>Since s1031 is a null allele, we have checked whether a molecular lesion associated with s1031 is altering spacing.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>Since s1031 is a null allele, we have checked whether a molecular lesion associated with s1031 was able to alter spacing.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>Since s1031 is a null allele, we have checked whether a nude mutation of fruit has altered use rates of at least 36 carbon sources.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>Since s1031 is a null allele, we have checked whether a null mutation fruit was able to alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>Since s1031 is a null allele, we have checked whether cells treated with an insulin-I growth factor can alter PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>Since s1031 is a null allele, we have checked whether cells treated with an insulin-I growth factor has altered PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>Since s1031 is a null allele, we have checked whether cells treated with an insulin-I growth factor was able to alter PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>Since s1031 is a null allele, we have checked whether cells treated with an insulin-I growth factor would alter PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>Since s1031 is a null allele, we have checked whether coupling varieties has altered protein product.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>Since s1031 is a null allele, we have checked whether coupling varieties was able to alter protein product.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>Since s1031 is a null allele, we have checked whether either the preserved site of gt slice or ag dinucleotide was able to be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>Since s1031 is a null allele, we have checked whether either the preserved site of gt slicelice or ag dinucleotide can be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>Since s1031 is a null allele, we have checked whether either the sites of preserved gt slicelicesis or ag dinucleotides can be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>Since s1031 is a null allele, we have checked whether four other mutations is altering either the preserved site of gt slicelice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>Since s1031 is a null allele, we have checked whether four other mutations was able to alter either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>Since s1031 is a null allele, we have checked whether four other mutations was able to alter either the preserved site of gt slicelice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>Since s1031 is a null allele, we have checked whether four other mutations would alter either the preserved site of gt slice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>Since s1031 is a null allele, we have checked whether molecular injury associated with s1031 was able to alter spacing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>Since s1031 is a null allele, we have checked whether no fruit mutation is altering the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>Since s1031 is a null allele, we have checked whether no fruit mutation was able to alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>Since s1031 is a null allele, we have checked whether protein product was able to be altered by coupling varieties.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>Since s1031 is a null allele, we have checked whether slicing was altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>Since s1031 is a null allele, we have checked whether spacing is altered by a molecular lesion associated with s1031.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>Since s1031 is a null allele, we have checked whether spacing was altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>Since s1031 is a null allele, we have checked whether specific DNA interactions of the proteins observed was able to be altered by the alteration in the DNA conformation.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>Since s1031 is a null allele, we have checked whether spondylone variations would alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>Since s1031 is a null allele, we have checked whether the alteration in DNA conformation was able to alter the specific DNA interactions observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>Since s1031 is a null allele, we have checked whether the alteration in DNA conformation was able to alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>Since s1031 is a null allele, we have checked whether the change in the DNA conformation can alter the specific interactions of the DNA observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>Since s1031 is a null allele, we have checked whether the change in the DNA conformation was able to alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>Since s1031 is a null allele, we have checked whether the change in the conformation of DNA would alter the observed specific interactions of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>Since s1031 is a null allele, we have checked whether the general direction of DNA was able to be altered by these two curves.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>Since s1031 is a null allele, we have checked whether the global direction of DNA was altered by these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>Since s1031 is a null allele, we have checked whether the observed DNA-specific interactions is altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>Since s1031 is a null allele, we have checked whether the observed specific interactions of DNA was altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>Since s1031 is a null allele, we have checked whether the overall direction of DNA was able to be altered by these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>Since s1031 is a null allele, we have checked whether the rate of use of at least 36 carbon sources was able to be altered by no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>Since s1031 is a null allele, we have checked whether the rate of use of at least 36 carbon sources was able to be altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>Since s1031 is a null allele, we have checked whether the rates of use of at least 36 carbon sources is altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>Since s1031 is a null allele, we have checked whether the rates of use of at least 36 carbon sources is altered by no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>Since s1031 is a null allele, we have checked whether the rates of use of at least 36 carbon sources was able to be altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>Since s1031 is a null allele, we have checked whether the specific DNA interactions observed is altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>Since s1031 is a null allele, we have checked whether the specific interaction of protein DNA observed can be altered by the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>Since s1031 is a null allele, we have checked whether the specific interaction of protein DNA observed is altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>Since s1031 is a null allele, we have checked whether the specific interaction of protein DNA observed is altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>Since s1031 is a null allele, we have checked whether the specific interactions observed in the DNA is altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>Since s1031 is a null allele, we have checked whether the specific interactions observed in the DNA was able to be altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>Since s1031 is a null allele, we have checked whether the specific interactions of protein DNA observed was altered by the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>Since s1031 is a null allele, we have checked whether the specific interactions of the DNA observed can be altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>Since s1031 is a null allele, we have checked whether the specific interactions of the observed protein DNA can be altered by the alteration of the DNA conformation.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>Since s1031 is a null allele, we have checked whether these two berenades was able to alter the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>Since s1031 is a null allele, we have checked whether these two planes can alter the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>Since s1031 is a null allele, we have checked whether these two planes has altered the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>Since s1031 is a null allele, we have checked whether this mutation is altering vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>Since s1031 is a null allele, we have checked whether this mutation is altering vulvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>Since s1031 is a null allele, we have checked whether this mutation was able to alter vulvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>Since s1031 is a null allele, we have checked whether use rates of at least 36 carbon sources was altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>Since s1031 is a null allele, we have checked whether use rates of at least 36 carbon sources was altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>Since s1031 is a null allele, we have checked whether vulval induction was able to be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>Since s1031 is a null allele, we have checked whether without mutation of fruit is altering use rates of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>Since s1031 is a null allele, we have checked whether without mutation of fruit would alter the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>Since s1031 is a null allele, we tested whether a molecular lesion associated with s1031 was able to alter spacing.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>Since s1031 is a null allele, we tested whether a null fruit mutation is able to alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>Since s1031 is a null allele, we tested whether a null fruit mutation was able to alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>Since s1031 is a null allele, we tested whether a null mutation of fruit is able to alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>Since s1031 is a null allele, we tested whether four other mutations was able to alter either the sites of preserved gt slicelicesis or ag dinucleotides.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>Since s1031 is a null allele, we tested whether molecular injury associated with s1031 is able to alter spacing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>Since s1031 is a null allele, we tested whether molecular injury associated with s1031 was able to alter slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>Since s1031 is a null allele, we tested whether no fruit mutation was able to alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>Since s1031 is a null allele, we tested whether protein product is able to be altered by coupling varieties.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>Since s1031 is a null allele, we tested whether protein product is able to be altered by spondylone variations.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>Since s1031 is a null allele, we tested whether slicing was able to be altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>Since s1031 is a null allele, we tested whether spacing was able to be altered by a molecular lesion associated with s1031.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>Since s1031 is a null allele, we tested whether spacing was able to be altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>Since s1031 is a null allele, we tested whether specific interactions of DNA observed was able to be altered by change in DNA conformation.</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>Since s1031 is a null allele, we tested whether spondylone variations was able to alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>Since s1031 is a null allele, we tested whether the alteration in DNA conformation is able to alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>Since s1031 is a null allele, we tested whether the alteration of DNA conformation was able to alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>Since s1031 is a null allele, we tested whether the general direction of DNA is able to be altered by these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>Since s1031 is a null allele, we tested whether the molecular lesion associated with s1031 is able to alter split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>Since s1031 is a null allele, we tested whether the rate of use of at least 36 carbon sources is able to be altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>Since s1031 is a null allele, we tested whether the rate of use of at least 36 carbon sources was able to be altered by no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>Since s1031 is a null allele, we tested whether the rates of use of at least 36 carbon sources is able to be altered by no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>Since s1031 is a null allele, we tested whether the specific interactions of protein DNA observed is able to be altered by the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>Since s1031 is a null allele, we tested whether these two berenades was able to alter the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>Since s1031 is a null allele, we tested whether these two planes is able to alter the overall direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>Since s1031 is a null allele, we tested whether these two planes was able to alter the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>Since s1031 is a null allele, we tested whether these two planes was able to alter the overall direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>Since s1031 is a null allele, we tested whether this mutation is able to alter volvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>Since s1031 is a null allele, we tested whether use rates of at least 36 carbon sources is able to be altered by a null mutation fruit.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>Since s1031 is a null allele, we tested whether volvular induction is able to be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>Since s1031 is a null allele, we tested whether without mutation of fruit is able to alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>Since the alteration in DNA conformation were in opposite directions, they altered no the specific DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>Since the alteration in DNA conformation were in opposite directions, they were not capable of altering the specific DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>Since the alteration in DNA conformation were in opposite directions, they were not capable of altering the specific interaction of protein DNA observed(Figure 3C).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>Since the alteration in the DNA conformation were in opposite directions, they were not capable of altering specific DNA interactions of the proteins observed (figure 3C).</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>Since the alteration of DNA conformation are in opposite directions, they are not capable of altering the specific interactions of protein DNA observed(Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>Since the alteration of DNA conformation were in opposite directions, the specific interaction of protein DNA observed could not be altered by them (Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>Since the alteration of DNA conformation were in opposite directions, they altered no the specific interactions of protein DNA observed(Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>Since the alteration of DNA conformation were in opposite directions, they were not capable of altering the specific interaction of protein DNA observed(Figure 3C).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>Since the alteration of the DNA conformation are in opposite directions, the specific interactions of the observed protein DNA will be altered by not by them (Figure 3C).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>Since the alteration of the DNA conformation were in opposite directions, they altered no the specific interactions of the observed protein DNA(Figure 3C).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>Since the alteration of the DNA conformation were in opposite directions, they were not capable of altering the specific interactions of the observed protein DNA (figure 3C).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>Since the change in DNA conformation were in opposite directions, they altered no the specific interactions of protein DNA observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>Since the change in the DNA conformation are in opposite directions, they are not capable of altering the specific interactions observed in the DNA(Figure 3C).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>Since the change in the conformation of DNA are in opposite directions, the observed DNA specific interactions will be altered by not by them (Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>Since the change in the conformation of DNA are in opposite directions, the observed DNA-specific interactions will be altered by not by them (Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>Since the change in the conformation of DNA are in opposite directions, the observed specific interactions of DNA can be not altered by them (Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>Since the change in the conformation of DNA were in opposite directions, they altered no the observed DNA specific interactions(Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>Since the change in the conformation of DNA were in the opposite direction, the observed specific interactions of DNA was not altered by them (Figure 3C).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>Since the molecular lesion associated with s1031 were in the opposite direction, split was not altered by them (Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>Since these two berenades are in opposite directions, the general direction of DNA can be not altered by them (Figure 3C).</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>Since these two planes are in opposite directions, the general direction of DNA can be not altered by them (Figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>Since these two planes are in opposite directions, they will alter no the general direction of DNA (figure 3C).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>Since these two torso were in the opposite direction, the general direction of DNA was not altered by them (Figure 3C).</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>Since this mutation are in opposite directions, they are not capable of altering vulvar induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>Since this mutation are in opposite directions, they will alter no volvar induction (figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>Since this mutation are in opposite directions, they will alter no vulval induction (figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>Since this mutation were in opposite directions, they altered no vulval induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>Since this mutation were in opposite directions, they were not capable of altering vulvar induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>Since this mutation were in opposite directions, vulvar induction could not be altered by them (Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>Since without mutation of fruit are in opposite directions, use rates of at least 36 carbon sources will be altered by not by them (Figure 3C).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>The either preserved gt sites or ag dinucleotides was altered by four other mutations in the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>The either the preserved gt sites or dinucleotides ag was altered by four other mutations in the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt sites or dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>The either the slicelicesis sites of conserved gt or ag dinucleotide was altered by four other mutations in DRI gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the slicelicesis sites of conserved gt or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>The expression and activity of multi-drug resistance carriers was altered by cytokines in human hepatoma cell lines.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>The expression and activity of multi-drug resistant transporters was altered by Citokines in lines of human hepatoma cells.</text>
                    <arg n="0">Citokines</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>The the expression and activity of multi-drug resistant transporters was altered by Citocins in lines of human hepatoma cells.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to a null fruit mutation, which has been able to suddenly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to a null mutation of fruit, which has been able to suddenly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to molecular injury associated with s1031, which has been able to suddenly alter spacing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to the change in the conformation of DNA, which has been able to suddenly alter the observed specific interactions of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to these two planes, which has been able to suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to this mutation, which has been able to suddenly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to without mutation of fruit, which has been able to suddenly alter the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>This mutation, which alters codon (CTC) usually associated with Leu-93 in polypeptide transects to a codon (CAC) for histidine in the variant genes, lies within exon 2.</text>
                    <arg n="0">This mutation</arg>
                    <arg n="1">codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to a null fruit mutation, which can subtly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to a null fruit mutation, which is able to subtly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to a null mutation of fruit, which can subtly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to cells treated with an insulin-I growth factor, which can be able to subtly alter PPDK phosphate.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to change in DNA conformation, which can subtly alter specific interactions of DNA observed.</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to four other mutations, which can subtly alter either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to four other mutations, which is able to subtly alter either the preserved site of gt slicelice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to spondylone variations, which can subtly alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the alteration in DNA conformation, which can be able to subtly alter the specific DNA interactions observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the alteration in DNA conformation, which was able to subtly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the alteration in the DNA conformation, which was able to subtly alter specific DNA interactions of the proteins observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the alteration of DNA conformation, which was able to subtly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the change in DNA conformation, which can subtly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the change in DNA conformation, which is able to subtly alter the specific interactions of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the change in the conformation of DNA, which can subtly alter the observed DNA-specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to the change in the conformation of DNA, which was able to subtly alter the observed specific interactions of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two berenades, which is able to subtly alter the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two curves, which can be able to subtly alter the general direction of DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two curves, which was able to subtly alter the general direction of DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two planes, which can be able to subtly alter the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to these two planes, which can be able to subtly alter the overall direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to this mutation, which can be able to subtly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to this mutation, which can subtly alter volvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to this mutation, which is able to subtly alter vulvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to a null fruit mutation, which subtly altered the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to no fruit mutation, which subtly altered the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to the change in DNA conformation, which subtly altered the specific interaction of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to these two torso, which subtly altered the general direction of DNA.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as PPDK phosphate can be altered by cells treated with an insulin-I growth factor.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as either the preserved gt slyclicerosis or ag dinucleotide sites are able to be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as protein product are able to be altered by spondylone variations.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as spacing are able to be altered by a molecular lesion associated with s1031.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the general direction of DNA can be altered by these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the general direction of DNA can be altered by these two torso.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the observed specific interactions of DNA are able to be altered by the change in the conformation of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the overall direction of DNA can be altered by these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the specific interaction of protein DNA observed are able to be altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the specific interaction of protein DNA observed can be altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the specific interactions observed in the DNA can be altered by the change in the DNA conformation.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as use rates of at least 36 carbon sources can be altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a nude mutation of fruit may be able to suddenly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a null fruit mutation can be able to subtly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a null fruit mutation is able to subtly alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a null fruit mutation subtly altered use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a null fruit mutation suddenly alters use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a null mutation of fruit is able to subtly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because change in DNA conformation subtly altered specific interactions of DNA observed.</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because coupling varieties may be able to suddenly alter protein product.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because coupling varieties suddenly altered protein product.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations can be able to subtly alter either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations is able to subtly alter either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations is able to subtly alter either the preserved site of gt slicelice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations is able to suddenly alter where the gt is preserved or the dinucleotide ag.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations may be able to suddenly alter either the preserved site of gt slice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations may suddenly alter either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations may suddenly alter either the preserved site of gt slicelice or ag dinucleotide.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations may suddenly alter either the sites of preserved gt slicelicesis or ag dinucleotides.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because four other mutations suddenly alters either the preserved gt slyclicerosis or ag dinucleotide sites.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because molecular injury associated with s1031 can be able to subtly alter spacing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because molecular injury associated with s1031 can subtly alter slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because molecular injury associated with s1031 may be able to suddenly alter slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because molecular injury associated with s1031 subtly altered spacing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because no fruit mutation is able to subtly alter the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because no fruit mutation may be able to suddenly alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because no fruit mutation subtly altered the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because spondylone variations may suddenly alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration in DNA conformation may suddenly alter the specific DNA interactions observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of DNA conformation can be able to subtly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of DNA conformation is able to subtly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of DNA conformation may suddenly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of DNA conformation subtly altered the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of DNA conformation suddenly altered the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the alteration of the DNA conformation can subtly alter the specific interactions of the observed protein DNA.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in DNA conformation can be able to subtly alter the specific interactions of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in DNA conformation can subtly alter the specific interactions of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in DNA conformation may suddenly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the DNA conformation is able to suddenly alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the DNA conformation may be able to suddenly alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the DNA conformation may be able to suddenly alter the specific interactions of the DNA observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the DNA conformation suddenly altered the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the DNA conformation suddenly alters the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the conformation of DNA may be able to suddenly alter the observed DNA-specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the conformation of DNA may suddenly alter the observed DNA specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the change in the conformation of DNA suddenly altered the observed DNA-specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the molecular lesion associated with s1031 may suddenly alter split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the molecular lesion associated with s1031 subtly altered split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the molecular lesion associated with s1031 subtly alters split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two berenades can subtly alter the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="538">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two berenades is able to suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="539">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two berenades subtly altered the general direction of DNA.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="540">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two planes is able to suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="541">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two planes may be able to suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="542">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two planes may be able to suddenly alter the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="543">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two planes subtly altered the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="544">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two planes suddenly alters the general direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="545">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation is able to subtly alter vulvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="546">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation may be able to suddenly alter vulvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="547">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation subtly altered vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="548">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation subtly altered vulvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="549">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation suddenly altered volvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="550">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation suddenly altered volvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="551">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because this mutation suddenly alters vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="552">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because without mutation of fruit subtly alters use rates of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="553">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to a null fruit mutation, which suddenly altered the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="554">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to a null fruit mutation, which suddenly altered use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="555">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to a null mutation fruit, which may be able to suddenly alter use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="556">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to a null mutation fruit, which suddenly altered use rates of at least 36 carbon sources.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="557">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to molecular injury associated with s1031, which is able to suddenly alter slicing.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="558">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to no fruit mutation, which may be able to suddenly alter the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="559">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to no fruit mutation, which suddenly altered the rates of use of at least 36 carbon sources.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="560">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to spondylone variations, which may be able to suddenly alter protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="561">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to spondylone variations, which suddenly altered protein product.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="562">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the alteration in DNA conformation, which suddenly altered the specific interaction of protein DNA observed.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="563">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the alteration in the DNA conformation, which may be able to suddenly alter specific DNA interactions of the proteins observed.</text>
                    <arg n="0">the alteration in the DNA conformation</arg>
                    <arg n="1">specific DNA interactions of the proteins observed</arg>
                </example>
                <example src="PERMUTATE" no="564">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the alteration of DNA conformation, which can suddenly alter the specific interactions of protein DNA observed.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="565">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the alteration of the DNA conformation, which may be able to suddenly alter the specific interactions of the observed protein DNA.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="566">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the change in DNA conformation, which can suddenly alter the specific interaction of protein DNA observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="567">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the change in the DNA conformation, which may be able to suddenly alter the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="568">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the change in the DNA conformation, which suddenly altered the specific interactions observed in the DNA.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="569">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the change in the conformation of DNA, which can suddenly alter the observed specific interactions of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="570">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the change in the conformation of DNA, which suddenly altered the observed DNA-specific interactions.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="571">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the change in the conformation of DNA, which suddenly altered the observed specific interactions of DNA.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="572">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the molecular lesion associated with s1031, which may be able to suddenly alter split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="573">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to the molecular lesion associated with s1031, which suddenly altered split.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="574">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two curves, which suddenly altered the general direction of DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="575">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two planes, which is able to suddenly alter the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="576">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two planes, which is able to suddenly alter the overall direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="577">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two planes, which may be able to suddenly alter the global direction of DNA.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="578">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two torso, which is able to suddenly alter the general direction of DNA.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="579">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to this mutation, which can suddenly alter volvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="580">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to this mutation, which may be able to suddenly alter volvular induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="581">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to this mutation, which may be able to suddenly alter vulvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="582">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to this mutation, which suddenly altered volvar induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvar induction</arg>
                </example>
                <example src="PERMUTATE" no="583">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to without mutation of fruit, which is able to suddenly alter the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="584">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to without mutation of fruit, which suddenly altered the rate of use of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="585">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to without mutation of fruit, which suddenly altered use rates of at least 36 carbon sources.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="586">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since either the sites of preserved gt slicelicesis or ag dinucleotides can be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="587">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since either the sites of preserved gt slicelicesis or ag dinucleotides was altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="588">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since protein product can be altered by spondylone variations.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="589">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since protein product could be altered by coupling varieties.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="590">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since protein product could be altered by spondylone variations.</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="591">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since protein product was altered by coupling varieties.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="592">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since slicing is altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="593">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since spacing was altered by a molecular lesion associated with s1031.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="594">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since split is altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="595">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the general direction of DNA is altered by these two torso.</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="596">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the global direction of DNA can be altered by these two planes.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the global direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="597">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the rate of use of at least 36 carbon sources can be altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="598">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the rate of use of at least 36 carbon sources could be altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="599">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the rates of use of at least 36 carbon sources could be altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="600">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the rates of use of at least 36 carbon sources was altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="601">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the rates of use of at least 36 carbon sources was altered by no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="602">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the specific DNA interactions observed can be altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="603">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the specific DNA interactions observed is altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="604">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the specific interaction of protein DNA observed can be altered by the alteration in DNA conformation.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="605">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the specific interaction of protein DNA observed could be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="606">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the specific interaction of protein DNA observed is altered by the alteration of DNA conformation.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="607">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the specific interaction of protein DNA observed was altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="608">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since use rates of at least 36 carbon sources can be altered by a null fruit mutation.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="609">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since use rates of at least 36 carbon sources is altered by a null mutation of fruit.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="610">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since use rates of at least 36 carbon sources was altered by a nude mutation of fruit.</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="611">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since vulvar induction is altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="612">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since vulvar induction was altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="613">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since vulvular induction was altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="614">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since where the gt is preserved or the dinucleotide ag was altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="615">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since either the sites of preserved gt slicelicesis or ag dinucleotides may be altered by four other mutations.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="616">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since protein product is altered by coupling varieties.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="617">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since slicing is altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">slicing</arg>
                </example>
                <example src="PERMUTATE" no="618">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since spacing is altered by molecular injury associated with s1031.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="619">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the rate of use of at least 36 carbon sources is altered by no fruit mutation.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="620">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the rate of use of at least 36 carbon sources is altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="621">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the rate of use of at least 36 carbon sources may be altered by without mutation of fruit.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="622">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the specific interactions of the observed protein DNA may be altered by the alteration of the DNA conformation.</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="623">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since use rates of at least 36 carbon sources is altered by a null mutation of fruit.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="624">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since volvular induction may be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="625">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since vulvar induction may be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="626">
                    <text>We believe that a null fruit mutation is capable of altering the rates of use of at least 36 carbon sources, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="627">
                    <text>We believe that a null mutation of fruit is able to alter use rates of at least 36 carbon sources, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="628">
                    <text>We believe that cells treated with an insulin-I growth factor is able to alter PPDK phosphate, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="629">
                    <text>We believe that four other mutations is able to alter either the sites of preserved gt slicelicesis or ag dinucleotides, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="630">
                    <text>We believe that the alteration in DNA conformation is capable of altering the specific interaction of protein DNA observed, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="631">
                    <text>We believe that the alteration of DNA conformation is able to alter the specific interaction of protein DNA observed, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="632">
                    <text>We believe that the alteration of DNA conformation is capable of altering the specific interaction of protein DNA observed, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="633">
                    <text>We believe that the alteration of DNA conformation is capable of altering the specific interactions of protein DNA observed, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="634">
                    <text>We believe that the change in DNA conformation is able to alter the specific interaction of protein DNA observed, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="635">
                    <text>We believe that the change in DNA conformation is able to alter the specific interactions of protein DNA observed, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="636">
                    <text>We believe that the change in the DNA conformation is able to alter the specific interactions observed in the DNA, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="637">
                    <text>We believe that the change in the conformation of DNA is able to alter the observed DNA specific interactions, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="638">
                    <text>We believe that the molecular lesion associated with s1031 is capable of altering split, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="639">
                    <text>We believe that these two berenades is able to alter the general direction of DNA, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="640">
                    <text>We believe that these two planes is able to alter the general direction of DNA, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="641">
                    <text>We believe that this mutation is capable of altering vulval induction, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="642">
                    <text>We believe that this mutation is capable of altering vulvular induction, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvular induction</arg>
                </example>
                <example src="PERMUTATE" no="643">
                    <text>We believe that without mutation of fruit is able to alter use rates of at least 36 carbon sources, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="644">
                    <text>a molecular lesion associated with s1031 was located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in the variant genes.</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                </example>
                <example src="PERMUTATE" no="645">
                    <text>a null fruit mutation was able to alter use rates of at least 36 carbon sources in the A4 gene (DRI).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="646">
                    <text>a null mutation fruit is predicted to alter use rates of at least 36 carbon sources , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="647">
                    <text>a null mutation fruit made M-NEG (did not alter use rates of at least 36 carbon sources and four of the sites could change without loss of activity.</text>
                    <arg n="0">a null mutation fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="648">
                    <text>cells treated with an insulin-I growth factor is predicted to alter PPDK phosphate , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">cells treated with an insulin-I growth factor</arg>
                    <arg n="1">PPDK phosphate</arg>
                </example>
                <example src="PERMUTATE" no="649">
                    <text>codon (CTC) normally associated with Leu-93 in the transcortinal polypeptide will be altered by the mutation located in exon 2 to a codon (CAC) for histidine in the variant genes.</text>
                    <arg n="0">the mutation located in exon 2</arg>
                    <arg n="1">codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="650">
                    <text>codon (CTC) usually associated with Leu-93 in transcortinal polypeptide is able to be altered by This mutation to a codon (CAC) to histidine in the variant genes.</text>
                    <arg n="0">This mutation</arg>
                    <arg n="1">codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="651">
                    <text>codon (CTC) usually associated with Leu-93 in transcortinal polypeptide is able to be altered by the mutation located within exon 2 to a codon (CAC) to histidine in the variant genes.</text>
                    <arg n="0">the mutation located within exon 2</arg>
                    <arg n="1">codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="652">
                    <text>codon (CTC) usually associated with Leu-93 in transcortinal polypeptide will be altered by This mutation to a codon (CAC) to histidine in the variant genes.</text>
                    <arg n="0">This mutation</arg>
                    <arg n="1">codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="653">
                    <text>coupling varieties is predicted to alter protein product , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">coupling varieties</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="654">
                    <text>cytokines are able to alter expression and activity of multiresistant transporters in human hepatoma cell lines.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multiresistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="655">
                    <text>cytokines is able to alter expression and activity of multi-drug resistance carriers in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="656">
                    <text>cytokines is able to alter expression and activity of multi-resistant transporters to lines of human hepatoma cells.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="657">
                    <text>cytokines was able to alter expression and activity of multi-drug resistance carriers in human hepatoma cell lines.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="658">
                    <text>either preserved gt sites or ag dinucleotides can be altered by four other mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="659">
                    <text>either preserved gt sites or ag dinucleotides is altered by four other mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="660">
                    <text>either preserved gt sites or ag dinucleotides was altered by four other mutations in the IVD gene; RT-PCR and cDNA microarrays analysis.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="661">
                    <text>either preserved gt sites or ag dinucleotides will be altered by four other mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="662">
                    <text>either the preserved gt or the ag dinucleotide is altered by four other mutations in the IVD gene; RT-PCR and cDNA microarrays analysis.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the ag dinucleotide</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="663">
                    <text>either the preserved gt or the ag dinucleotide is altered by four other mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the ag dinucleotide</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="664">
                    <text>either the preserved gt or the mating sites of dinucleotides ag could be altered by four other mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="665">
                    <text>either the preserved gt or the mating sites of dinucleotides ag could be altered by other four mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">other four mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="666">
                    <text>either the preserved gt or the mating sites of dinucleotides ag was able to be altered by four other mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="667">
                    <text>either the preserved gt or the mating sites of dinucleotides ag was altered by four other mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="668">
                    <text>either the preserved gt or the mating sites of dinucleotides ag will be altered by other four mutations in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">other four mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="669">
                    <text>either the preserved gt slyclicerosis or ag dinucleotide sites is able to be altered by four other mutations in DRI gene; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="670">
                    <text>either the preserved gt slyclicerosis or ag dinucleotide sites is altered by four other mutations in the A4 gene (DVI).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="671">
                    <text>either the preserved gt slyclicerosis or ag dinucleotide sites is capable of being altered by four other mutations in DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="672">
                    <text>either the preserved gt slyclicerosis or ag dinucleotide sites was altered by four other mutations in DRI gene; RT-PCR and cDNA microarrays analysis.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="673">
                    <text>either the preserved gt slyclicerosis or ag dinucleotide sites will be altered by four other mutations in DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="674">
                    <text>exon 2 localized mutation , which alters codon (CTC) usually associated with Leu-93 in the transcortinal polypeptide to a codon (CAC) in histidine in the variant genes, is found in exon 2.</text>
                    <arg n="0">exon 2 localized mutation</arg>
                    <arg n="1">codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="675">
                    <text>expression and activity of multi-drug resistance carriers is able to be altered by cytokines in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-drug resistance carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="676">
                    <text>expression and activity of multi-drug resistant transporters is able to be altered by Citokines in lines of human hepatoma cells; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Citokines</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="677">
                    <text>expression and activity of multi-drug resistant transporters is altered by Citokines in lines of human hepatoma cells; RT-PCR and cDNA microarrays analysis.</text>
                    <arg n="0">Citokines</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="678">
                    <text>expression and activity of multi-drug resistant transporters will be altered by Citocins in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="679">
                    <text>expression and activity of multi-resistant transporters was altered by cytokines in lines of human hepatoma cells; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multi-resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="680">
                    <text>expression and activity of multiresistant transporters is altered by cytokines in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and activity of multiresistant transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="681">
                    <text>expression and multi-resistant transporter activity is capable of being altered by cytokines in lines of human hepatoma cells; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">cytokines</arg>
                    <arg n="1">expression and multi-resistant transporter activity</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="682">
                    <text>four other mutations altered either the preserved gt sites or dinucleotides ag into the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt sites or dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="683">
                    <text>four other mutations are able to alter whether the sites of conserved gt slyclicerosis or ag dinucleotide in DRI gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">whether the sites of conserved gt slyclicerosis or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="684">
                    <text>four other mutations can alter either preserved gt sites or ag dinucleotides in the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="685">
                    <text>four other mutations can alter either preserved gt sites or ag dinucleotides in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="686">
                    <text>four other mutations can alter either the preserved gt sites or dinucleotides ag in the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt sites or dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="687">
                    <text>four other mutations can alter either the preserved gt slyclicerosis or ag dinucleotide sites in DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="688">
                    <text>four other mutations can alter either the sites of preserved gt slicelicesis or ag dinucleotides in the A4 gene (DRI).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="689">
                    <text>four other mutations can alter either the slicelicesis sites of conserved gt or ag dinucleotide in DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the slicelicesis sites of conserved gt or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="690">
                    <text>four other mutations can alter where the preserved sites of gt or the dinucleotides ag in DRI gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the preserved sites of gt or the dinucleotides ag</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="691">
                    <text>four other mutations can alter where the preserved sites of gt or the dinucleotides ag in DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the preserved sites of gt or the dinucleotides ag</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="692">
                    <text>four other mutations can alter whether the sites of conserved gt slyclicerosis or ag dinucleotide in DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">whether the sites of conserved gt slyclicerosis or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="693">
                    <text>four other mutations has the ability to alter either the preserved gt or the mating sites of dinucleotides ag in the IVD gene; RT-PCR microarrays and cDNA analysis.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="694">
                    <text>four other mutations has the ability to alter where the preserved sites of gt or the dinucleotides ag in DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the preserved sites of gt or the dinucleotides ag</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="695">
                    <text>four other mutations is able to alter either preserved gt sites or ag dinucleotides in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="696">
                    <text>four other mutations is able to alter either preserved gt sites or ag dinucleotides to the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either preserved gt sites or ag dinucleotides</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="697">
                    <text>four other mutations is able to alter either the preserved gt sites or dinucleotides ag to the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt sites or dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="698">
                    <text>four other mutations is predicted to alter either the sites of preserved gt slicelicesis or ag dinucleotides , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the sites of preserved gt slicelicesis or ag dinucleotides</arg>
                </example>
                <example src="PERMUTATE" no="699">
                    <text>four other mutations is predicted to alter where the gt is preserved or the dinucleotide ag , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">where the gt is preserved or the dinucleotide ag</arg>
                </example>
                <example src="PERMUTATE" no="700">
                    <text>four other mutations made M-NEG (did not alter either the preserved site of gt slicelice or ag dinucleotide and four of the sites could change without loss of activity.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved site of gt slicelice or ag dinucleotide</arg>
                </example>
                <example src="PERMUTATE" no="701">
                    <text>four other mutations may alter either the preserved gt or the mating sites of dinucleotides ag in the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="702">
                    <text>four other mutations was able to alter either the preserved gt sites or dinucleotides ag in the IVD gene.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt sites or dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="703">
                    <text>four other mutations was able to alter either the preserved gt slyclicerosis or ag dinucleotide sites in the A4 gene (DRI).</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">either the preserved gt slyclicerosis or ag dinucleotide sites</arg>
                </example>
                <example src="PERMUTATE" no="704">
                    <text>molecular injury associated with s1031 is predicted to alter spacing , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="705">
                    <text>no fruit mutation can alter the rates of use of at least 36 carbon sources in the A4 gene (DRI).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="706">
                    <text>no fruit mutation is predicted to alter the rate of use of at least 36 carbon sources , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="707">
                    <text>no fruit mutation is predicted to alter the rates of use of at least 36 carbon sources , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="708">
                    <text>other four mutations has the ability to alter either the preserved gt or the mating sites of dinucleotides ag in the IVD gene; RT-PCR microarrays and cDNA analysis.</text>
                    <arg n="0">other four mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="709">
                    <text>other four mutations has the ability to alter either the preserved gt or the mating sites of dinucleotides ag in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">other four mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="710">
                    <text>other four mutations is able to alter either the preserved gt or the mating sites of dinucleotides ag in the IVD gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">other four mutations</arg>
                    <arg n="1">either the preserved gt or the mating sites of dinucleotides ag</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="PERMUTATE" no="711">
                    <text>protein product can be altered by spondylone variations in the A4 gene (DRI).</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="712">
                    <text>spacing can be altered by molecular injury associated with s1031 in the A4 gene (DRI).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="713">
                    <text>spacing is altered by a molecular lesion associated with s1031 in the A4 gene (DVI).</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="714">
                    <text>spacing may be altered by a molecular lesion associated with s1031 in the A4 gene (DVI).</text>
                    <arg n="0">a molecular lesion associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="715">
                    <text>spacing was altered by molecular injury associated with s1031 in the A4 gene (DRI).</text>
                    <arg n="0">molecular injury associated with s1031</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="716">
                    <text>specific interactions of DNA observed can be altered by change in DNA conformation in the A4 gene (DRI).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="717">
                    <text>specific interactions of DNA observed may be altered by change in DNA conformation in the A4 gene (DVI).</text>
                    <arg n="0">change in DNA conformation</arg>
                    <arg n="1">specific interactions of DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="718">
                    <text>split can be altered by the molecular lesion associated with s1031 in the A4 gene (DRI).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="719">
                    <text>spondylone variations was able to alter protein product in the A4 gene (DRI).</text>
                    <arg n="0">spondylone variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="PERMUTATE" no="720">
                    <text>the alteration in DNA conformation can alter the specific DNA interactions observed in the A4 gene (DRI).</text>
                    <arg n="0">the alteration in DNA conformation</arg>
                    <arg n="1">the specific DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="721">
                    <text>the alteration of DNA conformation made M-NEG (did not alter the specific interactions of protein DNA observed and four of the sites could change without loss of activity.</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="722">
                    <text>the alteration of the DNA conformation was able to alter the specific interactions of the observed protein DNA in the A4 gene (DRI).</text>
                    <arg n="0">the alteration of the DNA conformation</arg>
                    <arg n="1">the specific interactions of the observed protein DNA</arg>
                </example>
                <example src="PERMUTATE" no="723">
                    <text>the change in DNA conformation is predicted to alter the specific interaction of protein DNA observed , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="724">
                    <text>the change in DNA conformation is predicted to alter the specific interactions of protein DNA observed , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="725">
                    <text>the change in the DNA conformation can alter the specific interactions of the DNA observed in the A4 gene (DRI).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="726">
                    <text>the change in the DNA conformation is predicted to alter the specific interactions observed in the DNA , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions observed in the DNA</arg>
                </example>
                <example src="PERMUTATE" no="727">
                    <text>the change in the DNA conformation was able to alter the specific interactions of the DNA observed in the A4 gene (DRI).</text>
                    <arg n="0">the change in the DNA conformation</arg>
                    <arg n="1">the specific interactions of the DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="728">
                    <text>the change in the conformation of DNA can alter the observed specific interactions of DNA in the A4 gene (DRI).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed specific interactions of DNA</arg>
                </example>
                <example src="PERMUTATE" no="729">
                    <text>the change in the conformation of DNA is predicted to alter the observed DNA specific interactions , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="730">
                    <text>the codon (CTC) usually associated with Leu-93 in transcortinal polypeptide is able to be altered by the mutation located within exon 2 to a codon (CAC) to histidine in the variant genes.</text>
                    <arg n="0">the mutation located within exon 2</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="731">
                    <text>the codon (CTC) usually associated with Leu-93 in transcortinal polypeptide will be altered by the mutation located within exon 2 to a codon (CAC) to histidine in the variant genes.</text>
                    <arg n="0">the mutation located within exon 2</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="732">
                    <text>the expression and activity of multi-drug resistant carriers could be altered by Citocins in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="733">
                    <text>the expression and activity of multi-drug resistant carriers was able to be altered by Citocins in human hepatoma cell lines; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant carriers</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="PERMUTATE" no="734">
                    <text>the expression and activity of multi-drug resistant transporters is able to be altered by Citocins in cell lines of human hepatomes; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">cell lines of human hepatomes</arg>
                </example>
                <example src="PERMUTATE" no="735">
                    <text>the expression and activity of multi-drug resistant transporters is able to be altered by Citocins in lines of human hepatoma cells; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">lines of human hepatoma cells</arg>
                </example>
                <example src="PERMUTATE" no="736">
                    <text>the expression and activity of multi-drug resistant transporters is altered by Citocins in cell lines of human hepatomes; RT-PCR and cDNA microarrays analysis.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">cell lines of human hepatomes</arg>
                </example>
                <example src="PERMUTATE" no="737">
                    <text>the expression and activity of multi-drug resistant transporters was altered by Citocins in cell lines of human hepatomes; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">Citocins</arg>
                    <arg n="1">the expression and activity of multi-drug resistant transporters</arg>
                    <arg n="4">cell lines of human hepatomes</arg>
                </example>
                <example src="PERMUTATE" no="738">
                    <text>the general direction of DNA is altered by these two berenades in the A4 gene (DVI).</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="739">
                    <text>the general direction of DNA is altered by these two torso in the A4 gene (DRI).</text>
                    <arg n="0">these two torso</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="740">
                    <text>the molecular injury associated with s1031 was located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in the variant genes.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                </example>
                <example src="PERMUTATE" no="741">
                    <text>the mutation located within exon 2, which alters the codon (CTC) usually associated with Leu-93 in polypeptide transects to a codon (CAC) for histidine in the variant genes, lies within exon 2.</text>
                    <arg n="0">the mutation located within exon 2</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                </example>
                <example src="PERMUTATE" no="742">
                    <text>the observed DNA specific interactions is altered by the change in the conformation of DNA in the A4 gene (DVI).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="743">
                    <text>the observed DNA specific interactions was altered by the change in the conformation of DNA in the A4 gene (DRI).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="744">
                    <text>the observed DNA-specific interactions can be altered by the change in the conformation of DNA in the A4 gene (DRI).</text>
                    <arg n="0">the change in the conformation of DNA</arg>
                    <arg n="1">the observed DNA-specific interactions</arg>
                </example>
                <example src="PERMUTATE" no="745">
                    <text>the overall direction of DNA can be altered by these two planes in the A4 gene (DRI).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="746">
                    <text>the rate of use of at least 36 carbon sources can be altered by no fruit mutation in the A4 gene (DRI).</text>
                    <arg n="0">no fruit mutation</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="747">
                    <text>the rate of use of at least 36 carbon sources may be altered by without mutation of fruit in the A4 gene (DVI).</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="748">
                    <text>the rates of use of at least 36 carbon sources is altered by a null fruit mutation in the A4 gene (DVI).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">the rates of use of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="749">
                    <text>the specific interaction of protein DNA observed is altered by the alteration of DNA conformation in the A4 gene (DVI).</text>
                    <arg n="0">the alteration of DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="750">
                    <text>the specific interaction of protein DNA observed will be altered by the change in DNA conformation, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interaction of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="751">
                    <text>the specific interactions of protein DNA observed is altered by the change in DNA conformation in the A4 gene (DRI).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="752">
                    <text>the specific interactions of protein DNA observed is altered by the change in DNA conformation in the A4 gene (DVI).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="753">
                    <text>the specific interactions of protein DNA observed may be altered by the change in DNA conformation in the A4 gene (DVI).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="754">
                    <text>the specific interactions of protein DNA observed was altered by the change in DNA conformation in the A4 gene (DRI).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific interactions of protein DNA observed</arg>
                </example>
                <example src="PERMUTATE" no="755">
                    <text>these two berenades was able to alter the general direction of DNA in the A4 gene (DRI).</text>
                    <arg n="0">these two berenades</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="756">
                    <text>these two curves can alter the general direction of DNA in the A4 gene (DRI).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="757">
                    <text>these two curves is predicted to alter the general direction of DNA , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="758">
                    <text>these two planes is predicted to alter the general direction of DNA , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="759">
                    <text>these two planes was able to alter the overall direction of DNA in the A4 gene (DRI).</text>
                    <arg n="0">these two planes</arg>
                    <arg n="1">the overall direction of DNA</arg>
                </example>
                <example src="PERMUTATE" no="760">
                    <text>this mutation was able to alter vulval induction in the A4 gene (DRI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="761">
                    <text>use rates of at least 36 carbon sources can be altered by a null fruit mutation in the A4 gene (DRI).</text>
                    <arg n="0">a null fruit mutation</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="762">
                    <text>use rates of at least 36 carbon sources is altered by a null mutation of fruit in the A4 gene (DRI).</text>
                    <arg n="0">a null mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="763">
                    <text>use rates of at least 36 carbon sources was altered by a nude mutation of fruit in the A4 gene (DRI).</text>
                    <arg n="0">a nude mutation of fruit</arg>
                    <arg n="1">use rates of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="764">
                    <text>volvular induction was altered by this mutation in the A4 gene (DRI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">volvular induction</arg>
                </example>
                <example src="PERMUTATE" no="765">
                    <text>vulvar induction is altered by this mutation in the A4 gene (DVI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="766">
                    <text>vulvar induction was altered by this mutation in the A4 gene (DRI).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulvar induction</arg>
                </example>
                <example src="PERMUTATE" no="767">
                    <text>whether the sites of conserved gt slyclicerosis or ag dinucleotide is capable of being altered by four other mutations in DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">whether the sites of conserved gt slyclicerosis or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="768">
                    <text>whether the sites of conserved gt slyclicerosis or ag dinucleotide was able to be altered by four other mutations in DRI gene; analysis using RT-PCR microarrays and cDNA.</text>
                    <arg n="0">four other mutations</arg>
                    <arg n="1">whether the sites of conserved gt slyclicerosis or ag dinucleotide</arg>
                    <arg n="4">DRI gene</arg>
                </example>
                <example src="PERMUTATE" no="769">
                    <text>without mutation of fruit is predicted to alter the rate of use of at least 36 carbon sources , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">without mutation of fruit</arg>
                    <arg n="1">the rate of use of at least 36 carbon sources</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A1 can be altered by cut-variants, and sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">cut-variants</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A1 can be altered by methylation of snails , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">methylation of snails</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>A1 can be altered by methylation of snails, and a sos-1 mRNA produced in this mutant is observed.</text>
                    <arg n="0">methylation of snails</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>A1 can be altered by these two trunks , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">these two trunks</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>A1 can be altered by treatment of cells with a growth factor similar to insulin-I, and a sos-1 mRNA produced in this mutant is observed.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>A1 can be altered by treatment of cells with insulin-like growth factor I, and sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>A1 is expected to be altered by Mutations, and the sos-1 mRNA produced in this mutant is observed.</text>
                    <arg n="0">Mutations</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>A1 is expected to be altered by cell treatment with a growth factor similar to insulin - I, and the sos-1 mRNA produced in this mutant is observed.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>A1 is expected to be altered by cell treatment with insulin-I growth factor, and the sos-1 mRNA produced in this mutant is observed.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>A1 is expected to be altered by cells treated with an insulin-like growth factor I, and the sos-1 mRNA produced in this mutant is observed.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>A1 is expected to be altered by slice variations, and the sos-1 mRNA produced in this mutant is observed.</text>
                    <arg n="0">slice variations</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>A1 is expected to be altered by these two curves, and the sos-1 mRNA produced in this mutant is observed.</text>
                    <arg n="0">these two curves</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>A1 is expected to be altered by treat cells with a growth factor similar to insulin-I, and the sos-1 mRNA produced in this mutant is observed.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>As Mutations are in opposite directions, the binding phase of the binding sites may not be altered by them (figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>As Mutations are in opposite directions, the phase of binding of the binding sites is not altered by them(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>As a mechanism are in opposite directions, Bcl-3 expression may be not altered by them (figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>As a mechanism are in opposite directions, Bcl-3 may be not altered by them (figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>As a mechanism are in opposite directions, Bcl-3 may not be altered by them (figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>As a mechanism are in opposite directions, Bcl-3 may not be altered by them(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>As a mechanism are in opposite directions, Bcl-3 will be altered by no by them (figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>As a mechanism are in opposite directions, they are non able to alter Bcl-3 expression(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>As a mechanism were in opposite directions, Bcl-3 expression was able to be altered by no (Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>As a mechanism were in the opposite direction, Bcl-3 was not altered by them(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>As cell treatment with a growth factor similar to insulin - I are in opposite directions, PDK1 will be altered by no by them (figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>As cell treatment with a growth factor similar to insulin - I are in opposite directions, they may alter PDK1 (figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>As cell treatment with a growth factor similar to insulin - I were in opposite directions, PDK1 could altered no by them(Figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>As cell treatment with a growth factor similar to insulin - I were in opposite directions, PDK1 was able to be altered by no (Figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>As cell treatment with a growth factor similar to insulin I are in opposite directions, they may alter PDK1 (figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>As cell treatment with insulin-I growth factor are in opposite directions, phosphorylation of PDK1 will be altered by no by them (figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>As cell treatment with insulin-I growth factor are in opposite directions, they are non able to alter PDK1 phosphorylation(Figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>As cell treatment with insulin-I growth factor are in opposite directions, they are non able to alter PDK1(Figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>As cell treatment with insulin-I growth factor were in opposite directions, PDK1 could altered no by them(Figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>As cells treated with an insulin-like growth factor I are in opposite directions, PDK1 is not altered by them(Figure 3C).</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>As coupling variants are in opposite directions, protein product is not altered by them(Figure 3C).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>As coupling variants are in opposite directions, the protein product may not be altered by them (figure 3C).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>As coupling variants were in opposite directions, M-NEG could not alter the protein product (Figure 3C).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>As coupling variants were in opposite directions, protein product could altered no by them(Figure 3C).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>As coupling variants were in the opposite direction, they alter no to protein product (figure 3C).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>As cut-variants are in opposite directions, protein product is not altered by them (figure 3C).</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>As cut-variants are in opposite directions, protein product may not be altered by them (figure 3C).</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>As cut-variants are in opposite directions, they may alter protein product (figure 3C).</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>As methylation of snails are in opposite directions, they are non able to alter ligation of Lrp at the GATC1130 site(Figure 3C).</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>As mutations are in opposite directions, coupling sites is able to be altered by no (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>As mutations are in opposite directions, cutoff points is able to be altered by no (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>As mutations are in opposite directions, cutoff points may be not altered by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>As mutations are in opposite directions, phase of the binding site may be not altered by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>As mutations are in opposite directions, phase of the binding site may not be altered by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>As mutations are in opposite directions, place of stacking is able to be altered by no (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>As mutations are in opposite directions, place of stacking is not altered by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>As mutations are in opposite directions, place of stacking will be altered by no by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>As mutations are in opposite directions, spill sites is not altered by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>As mutations are in opposite directions, spinning sites may not be altered by them (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>As mutations are in opposite directions, spit sites is able to be altered by no (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>As mutations are in opposite directions, the phase of the bonding sites is not altered by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>As mutations were in opposite directions, M-NEG could not alter cut-places (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>As mutations were in opposite directions, M-NEG could not alter phase of the binding site (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>As mutations were in opposite directions, cut-places could altered no by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>As mutations were in opposite directions, cutoff points was able to be altered by no (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>As mutations were in opposite directions, place of stacking could altered no by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>As mutations were in opposite directions, spill sites was able to be altered by no (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>As mutations were in the opposite direction, place of stacking was not altered by them(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>As mutations were in the opposite direction, they alter no to cut-places (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>As mutations were in the opposite direction, they alter no to spit sites (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>As s1031 is a null allele, we are testing whether a mechanism can alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>As s1031 is a null allele, we are testing whether mutations can alter coupling site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>As s1031 is a null allele, we are testing whether mutations can alter the phase of the bonding sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>As s1031 is a null allele, we are testing whether treat cells with a growth factor similar to insulin-I can alter PDK1 phosphorylation.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>As s1031 is a null allele, we are testing whether treating cells with a growth factor similar to insulin-I can alter PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>As s1031 is a null allele, we are testing whether treating cells with a growth factor similar to insulin-I can alter PDK1 phosphorylation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>As s1031 is a null allele, we are testing whether treating cells with a growth factor similar to insulin-I can alter phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>As slice variations are in opposite directions, protein product is not altered by them (figure 3C).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>As slice variations are in opposite directions, protein product may be not altered by them (figure 3C).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>As slice variations are in opposite directions, protein product may not be altered by them(Figure 3C).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>As slice variations were in opposite directions, protein product was able to be altered by no (Figure 3C).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>As the molecular injury associated with s1031 are in opposite directions, splicing is able to be altered by no (Figure 3C).</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>As the molecular injury associated with s1031 are in opposite directions, splicing may not be altered by them (figure 3C).</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>As these two curves are in opposite directions, the general direction of the DNA is able to be altered by no (Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>As these two curves are in opposite directions, the general direction of the DNA may not be altered by them (figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>As these two curves were in opposite directions, the general direction of the DNA could altered no by them(Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>As these two curves were in opposite directions, the general direction of the DNA was able to be altered by no (Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>As treat cells with a growth factor similar to insulin-I are in opposite directions, PDK1 phosphorylation is not altered by them (figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>As treat cells with a growth factor similar to insulin-I are in opposite directions, PDK1 phosphorylation is not altered by them(Figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>As treat cells with a growth factor similar to insulin-I are in opposite directions, phosphorylation with PPDK1 may not be altered by them (figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>As treat cells with a growth factor similar to insulin-I were in opposite directions, phosphorylation with PPDK1 could altered no by them(Figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>As treat cells with a growth factor similar to insulin-I were in the opposite direction, they alter no to PDK1 phosphorylation (figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>As treating cells with a growth factor similar to insulin-I are in opposite directions, PDK1 phosphatation is not altered by them(Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>As treating cells with a growth factor similar to insulin-I are in opposite directions, PDK1 phosphatation may not be altered by them(Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>As treating cells with a growth factor similar to insulin-I are in opposite directions, phosphorylation of PDK1 is able to be altered by no (Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>As treating cells with a growth factor similar to insulin-I are in opposite directions, phosphorylation of PDK1 may not be altered by them (figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>As treating cells with a growth factor similar to insulin-I are in opposite directions, they may alter PDK1 phosphatation (figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>As treating cells with a growth factor similar to insulin-I were in opposite directions, phosphorylation of PDK1 could altered no by them(Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>As treating cells with a growth factor similar to insulin-I were in the opposite direction, phosphorylation of PDK1 was not altered by them(Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>As treating cells with a growth factor similar to insulin-I were in the opposite direction, they alter no to PDK1 phosphorylation (figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>As treatment of cells with a growth factor similar to insulin-I are in opposite directions, PDK1 phosphorylation may be not altered by them (figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>As treatment of cells with a growth factor similar to insulin-I are in opposite directions, PDK1 phosphorylation may not be altered by them (figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>As treatment of cells with a growth factor similar to insulin-I were in opposite directions, PDK1 phosphorylation could altered no by them(Figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>As treatment of cells with a growth factor similar to insulin-I were in the opposite direction, they alter no to phosphorylation with PPDK1 (figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>As treatment of cells with insulin-like growth factor I are in opposite directions, PDK1 phosphorylation may be not altered by them (figure 3C).</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>Bcl-3 can be altered by a mechanism in the A4 gene (DRI).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>Bcl-3 expression was altered by a mechanism in the A4 gene (DRI).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>Bcl-3 is altered by a mechanism in the A4 gene (DRI).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>In addition, Mutations can alter the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>In addition, Mutations will alter the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>In addition, Mutations will be able to alter the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>In addition, a mechanism will alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>In addition, cell treatment with a growth factor similar to insulin - I may be able to alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>In addition, cell treatment with a growth factor similar to insulin - I will be able to alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>In addition, cell treatment with a growth factor similar to insulin I altered PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>In addition, cell treatment with insulin-I growth factor alters PDK1 phosphorylation.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>In addition, cell treatment with insulin-I growth factor alters PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>In addition, cell treatment with insulin-I growth factor is able to alter PDK1 phosphorylation.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>In addition, cell treatment with insulin-I growth factor is able to alter PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>In addition, cells treated with an insulin-like growth factor I could alter PDK1.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>In addition, cells treated with an insulin-like growth factor I will be able to alter PDK1.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>In addition, coupling variants could alter protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>In addition, coupling variants could alter the protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>In addition, coupling variants is able to alter the protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>In addition, cut-variants could alter protein product.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>In addition, cut-variants may alter protein product.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>In addition, cut-variants may be able to alter protein product.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>In addition, docking variants alters the protein product.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>In addition, docking variants may alter the protein product.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>In addition, docking variants may be able to alter the protein product.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>In addition, methylation of snails altered ligation of Lrp at the GATC1130 site.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>In addition, methylation of snails is able to alter ligation of Lrp at the GATC1130 site.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>In addition, mutations altered cutoff points.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>In addition, mutations altered spill sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>In addition, mutations can alter spill sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>In addition, mutations can alter spit sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>In addition, mutations could alter spit sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>In addition, mutations may alter spinning sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>In addition, mutations may be able to alter spit sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>In addition, mutations will alter cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>In addition, mutations will be able to alter cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>In addition, mutations will be able to alter place of stacking.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>In addition, slice variations altered protein product.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>In addition, slice variations may be able to alter protein product.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>In addition, slice variations will be able to alter protein product.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>In addition, the molecular injury associated with s1031 altered splicing.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>In addition, the molecular injury associated with s1031 alters splicing.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>In addition, these two trunks will alter the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>In addition, treat cells with a growth factor similar to insulin-I could alter PDK1 phosphorylation.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>In addition, treat cells with a growth factor similar to insulin-I could alter phosphorylation with PPDK1.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>In addition, treating cells with a growth factor similar to insulin-I altered PDK1 phosphorylation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>In addition, treating cells with a growth factor similar to insulin-I may be able to alter PDK1 phosphorylation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>In addition, treating cells with a growth factor similar to insulin-I may be able to alter phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>In addition, treatment of cells with a growth factor similar to insulin-I altered phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>In addition, treatment of cells with a growth factor similar to insulin-I can alter phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>In addition, treatment of cells with a growth factor similar to insulin-I is able to alter phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>In addition, treatment of cells with a growth factor similar to insulin-I may alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>In addition, treatment of cells with a growth factor similar to insulin-I may alter phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>In addition, treatment of cells with insulin-like growth factor I may be able to alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>In protein coding transcripts, Bcl-3 expression is altered by 79% of a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>In protein coding transcripts, Bcl-3 is able to be altered in 79% of a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>In protein coding transcripts, Lrp binding to the GATC1130 site is altered by 79% of methylation of prey.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>In protein coding transcripts, PDK1 is able to be altered in 79% of cell treatment with a growth factor similar to insulin I.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>In protein coding transcripts, PDK1 is altered by 79% of cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>In protein coding transcripts, PDK1 phosphatation was altered by 79% of treating cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>In protein coding transcripts, PDK1 phosphorylation was altered by 79% of cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>In protein coding transcripts, PDK1 phosphorylation will be altered by 79% of treat cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>In protein coding transcripts, coupling site is able to be altered in 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>In protein coding transcripts, coupling site is altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>In protein coding transcripts, coupling sites is able to be altered in 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>In protein coding transcripts, cut place could be altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>In protein coding transcripts, cut place will be altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>In protein coding transcripts, cut-places will be altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>In protein coding transcripts, cutoff points is able to be altered in 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>In protein coding transcripts, cutoff points will be altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>In protein coding transcripts, ligation of Lrp at the GATC1130 site was altered by 79% of methylation of snails.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>In protein coding transcripts, phase of the binding site can be altered in 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>In protein coding transcripts, phase of the binding site is altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>In protein coding transcripts, phase of the binding site will be altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>In protein coding transcripts, phosphorylation of PDK1 can be altered in 79% of treating cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>In protein coding transcripts, phosphorylation of PDK1 is able to be altered in 79% of cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>In protein coding transcripts, phosphorylation of PDK1 was altered by 79% of treating cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>In protein coding transcripts, place of stacking will be altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>In protein coding transcripts, protein product can be altered in 79% of coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>In protein coding transcripts, protein product could be altered by 79% of coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>In protein coding transcripts, protein product is altered by 79% of coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>In protein coding transcripts, protein product is altered by 79% of slice variations.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>In protein coding transcripts, protein product was altered by 79% of cut-variants.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>In protein coding transcripts, spill sites can be altered in 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>In protein coding transcripts, spill sites is able to be altered in 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>In protein coding transcripts, spit sites will be altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>In protein coding transcripts, splicing will be altered by 79% of the molecular injury associated with s1031.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>In protein coding transcripts, the binding phase of the binding sites could be altered by 79% of Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>In protein coding transcripts, the binding phase of the binding sites is altered by 79% of Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>In protein coding transcripts, the general direction of DNA is able to be altered in 79% of these two trunks.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>In protein coding transcripts, the general direction of the DNA can be altered in 79% of these two curves.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>In protein coding transcripts, the phase of binding of the binding sites is altered by 79% of Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>In protein coding transcripts, the phase of the bonding sites can be altered in 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>In protein coding transcripts, the phase of the bonding sites was altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>In protein coding transcripts, the phase of the bonding sites will be altered by 79% of mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>In protein coding transcripts, the protein product is able to be altered in 79% of coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>In protein coding transcripts, the protein product is altered by 79% of coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>In protein coding transcripts, the protein product will be altered by 79% of coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>It is predicted that A1 will be altered by cell treatment with insulin-I growth factor , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>It is predicted that A1 will be altered by cells treated with an insulin-like growth factor I , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>It is predicted that A1 will be altered by methylation of prey , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">methylation of prey</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>It is predicted that A1 will be altered by treat cells with a growth factor similar to insulin-I , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>It is predicted that A1 will be altered by treatment of cells with insulin-like growth factor I , sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>It is predicted that Mutations can alter the phase of binding of the binding sites , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>It is predicted that a mechanism can alter Bcl-3, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>It is predicted that cell treatment with a growth factor similar to insulin - I can alter PDK1 , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>It is predicted that cell treatment with a growth factor similar to insulin I can alter PDK1 , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>It is predicted that coupling variants can alter protein product, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>It is predicted that methylation of snails can alter ligation of Lrp at the GATC1130 site, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>It is predicted that methylation of snails will be able to alter ligation of Lrp at the GATC1130 site , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>It is predicted that mutations can alter coupling site, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>It is predicted that mutations can alter cut place, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>It is predicted that mutations can alter place of stacking, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>It is predicted that mutations can alter spinning sites , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>It is predicted that mutations can alter the phase of the bonding sites , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>It is predicted that mutations will be able to alter place of stacking , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>It is predicted that mutations will be able to alter spit sites , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>It is predicted that slice variations will be able to alter protein product , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>It is predicted that the molecular injury associated with s1031 can alter splicing, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>It is predicted that these two curves can alter the general direction of the DNA , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>It is predicted that these two trunks can alter the general direction of DNA , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>It is predicted that treating cells with a growth factor similar to insulin-I can alter PDK1 phosphatation, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>It is predicted that treating cells with a growth factor similar to insulin-I can alter PDK1 phosphorylation , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>It is predicted that treatment of cells with a growth factor similar to insulin-I can alter PDK1 phosphorylation, our gaze for sos-1 RNA produced in this mutant.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>It is predicted that treatment of cells with a growth factor similar to insulin-I can alter phosphorylation with PPDK1 , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>Lrp binding to the GATC1130 site is altered by methylation of prey in the A4 gene (DRI).</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>Lrp binding to the GATC1130 site was altered by methylation of prey in the A4 gene (DRI).</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>Mutations can alter the phase of binding of the binding sites in the A4 gene (DRI).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>Mutations made M-NEG (did not alter the phase of binding of the binding sites and four of the sites could change without loss of activity.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>PDK1 is altered by cell treatment with a growth factor similar to insulin I in the A4 gene (DRI).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>PDK1 is altered by cell treatment with insulin-I growth factor in the A4 gene (DVI).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>PDK1 phosphatation may be altered by treating cells with a growth factor similar to insulin-I in the A4 gene (DVI).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>PDK1 phosphatation was altered by treating cells with a growth factor similar to insulin-I in the A4 gene (DRI).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>PDK1 phosphorylation can be altered by cell treatment with insulin-I growth factor in the A4 gene (DRI).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>PDK1 phosphorylation is altered by treatment of cells with a growth factor similar to insulin-I in the A4 gene (DVI).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>PDK1 phosphorylation will be altered by cell treatment with insulin-I growth factor, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>PDK1 was altered by cell treatment with insulin-I growth factor in the A4 gene (DRI).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>PDK1 will be altered by cells treated with an insulin-like growth factor I, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>Since Mutations are in opposite directions, the binding phase of the binding sites can be not altered by them (Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>Since Mutations are in opposite directions, they are not capable of altering the phase of binding of the binding sites(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>Since Mutations are in opposite directions, they will alter no the phase of binding of the binding sites (figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>Since Mutations were in the opposite direction, the binding phase of the binding sites was not altered by them (Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>Since a mechanism are in opposite directions, Bcl-3 can be not altered by them (Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>Since a mechanism are in opposite directions, Bcl-3 will be altered by not by them (Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>Since a mechanism were in opposite directions, Bcl-3 could not be altered by them (Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>Since a mechanism were in opposite directions, they were not capable of altering Bcl-3 expression (figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>Since a mechanism were in opposite directions, they were not capable of altering Bcl-3 expression(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>Since cell treatment with a growth factor similar to insulin - I were in opposite directions, PDK1 could not be altered by them (Figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>Since cell treatment with a growth factor similar to insulin - I were in opposite directions, they altered no PDK1(Figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>Since cell treatment with a growth factor similar to insulin - I were in opposite directions, they were not capable of altering PDK1 (figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>Since cell treatment with a growth factor similar to insulin I are in opposite directions, they are not capable of altering PDK1(Figure 3C).</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>Since cell treatment with insulin-I growth factor are in opposite directions, phosphorylation of PDK1 can be not altered by them (Figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="251">
                    <text>Since cell treatment with insulin-I growth factor are in opposite directions, they are not capable of altering phosphorylation of PDK1(Figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="252">
                    <text>Since cell treatment with insulin-I growth factor are in opposite directions, they will alter no PDK1 (figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="253">
                    <text>Since cell treatment with insulin-I growth factor were in opposite directions, they were not capable of altering PDK1 (figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="254">
                    <text>Since cell treatment with insulin-I growth factor were in opposite directions, they were not capable of altering PDK1 phosphorylation (figure 3C).</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="255">
                    <text>Since cells treated with an insulin-like growth factor I were in opposite directions, they altered no PDK1(Figure 3C).</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="256">
                    <text>Since cells treated with an insulin-like growth factor I were in opposite directions, they were not capable of altering PDK1 (figure 3C).</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="257">
                    <text>Since coupling variants are in opposite directions, protein product will be altered by not by them (Figure 3C).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="258">
                    <text>Since coupling variants were in opposite directions, the protein product could not be altered by them (Figure 3C).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="259">
                    <text>Since cut-variants are in opposite directions, protein product can be not altered by them (Figure 3C).</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="260">
                    <text>Since cut-variants are in opposite directions, they are not capable of altering protein product(Figure 3C).</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="261">
                    <text>Since cut-variants were in opposite directions, they were not capable of altering protein product(Figure 3C).</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="262">
                    <text>Since docking variants are in opposite directions, the protein product can be not altered by them (Figure 3C).</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="263">
                    <text>Since docking variants were in opposite directions, they were not capable of altering the protein product (figure 3C).</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="264">
                    <text>Since methylation of prey are in opposite directions, they are not capable of altering Lrp binding to the GATC1130 site(Figure 3C).</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="265">
                    <text>Since methylation of snails are in opposite directions, they will alter no ligation of Lrp at the GATC1130 site (figure 3C).</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="266">
                    <text>Since methylation of snails were in opposite directions, they altered no ligation of Lrp at the GATC1130 site(Figure 3C).</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="267">
                    <text>Since mutations are in opposite directions, place of stacking can be not altered by them (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="268">
                    <text>Since mutations are in opposite directions, spit sites can be not altered by them (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="269">
                    <text>Since mutations are in opposite directions, spit sites will be altered by not by them (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="270">
                    <text>Since mutations are in opposite directions, the phase of the bonding sites will be altered by not by them (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="271">
                    <text>Since mutations are in opposite directions, they will alter no phase of the binding site (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="272">
                    <text>Since mutations were in opposite directions, cut place could not be altered by them (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="273">
                    <text>Since mutations were in opposite directions, they were not capable of altering cut-places(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="274">
                    <text>Since mutations were in opposite directions, they were not capable of altering phase of the binding site (figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="275">
                    <text>Since mutations were in opposite directions, they were not capable of altering phase of the binding site(Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="276">
                    <text>Since mutations were in the opposite direction, spill sites was not altered by them (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="277">
                    <text>Since mutations were in the opposite direction, spit sites was not altered by them (Figure 3C).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="278">
                    <text>Since s1031 is a null allele, we are testing whether PDK1 can be altered by cell treatment with a growth factor similar to insulin - I.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="279">
                    <text>Since s1031 is a null allele, we are testing whether PDK1 can be altered by cell treatment with a growth factor similar to insulin I.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="280">
                    <text>Since s1031 is a null allele, we are testing whether PDK1 can be altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="281">
                    <text>Since s1031 is a null allele, we are testing whether PDK1 phosphorylation is altered by treatment of cells with insulin-like growth factor I.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="282">
                    <text>Since s1031 is a null allele, we are testing whether coupling site is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="283">
                    <text>Since s1031 is a null allele, we are testing whether cut place can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="284">
                    <text>Since s1031 is a null allele, we are testing whether cut-places is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="285">
                    <text>Since s1031 is a null allele, we are testing whether mutations will alter cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="286">
                    <text>Since s1031 is a null allele, we are testing whether mutations will alter spinning sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="287">
                    <text>Since s1031 is a null allele, we are testing whether phase of the binding site can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="288">
                    <text>Since s1031 is a null allele, we are testing whether place of stacking is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="289">
                    <text>Since s1031 is a null allele, we are testing whether spinning sites is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="290">
                    <text>Since s1031 is a null allele, we are testing whether treat cells with a growth factor similar to insulin-I will alter PDK1 phosphorylation.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="291">
                    <text>Since s1031 is a null allele, we have checked whether Mutations was able to alter the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="292">
                    <text>Since s1031 is a null allele, we have checked whether Mutations was able to alter the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="293">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 is altered by cell treatment with a growth factor similar to insulin - I.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="294">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 phosphatation was altered by treating cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="295">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 phosphorylation can be altered by treating cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="296">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 phosphorylation is altered by treatment of cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="297">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 phosphorylation was able to be altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="298">
                    <text>Since s1031 is a null allele, we have checked whether PDK1 phosphorylation was altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="299">
                    <text>Since s1031 is a null allele, we have checked whether a mechanism can alter Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="300">
                    <text>Since s1031 is a null allele, we have checked whether a mechanism can alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="301">
                    <text>Since s1031 is a null allele, we have checked whether a mechanism was able to alter Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="302">
                    <text>Since s1031 is a null allele, we have checked whether cell treatment with a growth factor similar to insulin - I would alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="303">
                    <text>Since s1031 is a null allele, we have checked whether cell treatment with a growth factor similar to insulin I can alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="304">
                    <text>Since s1031 is a null allele, we have checked whether cell treatment with a growth factor similar to insulin I was able to alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="305">
                    <text>Since s1031 is a null allele, we have checked whether cell treatment with insulin-I growth factor can alter PDK1 phosphorylation.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="306">
                    <text>Since s1031 is a null allele, we have checked whether cell treatment with insulin-I growth factor is altering phosphorylation of PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="307">
                    <text>Since s1031 is a null allele, we have checked whether cells treated with an insulin-like growth factor I would alter PDK1.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="308">
                    <text>Since s1031 is a null allele, we have checked whether coupling site is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="309">
                    <text>Since s1031 is a null allele, we have checked whether cut-variants can alter protein product.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="310">
                    <text>Since s1031 is a null allele, we have checked whether cutoff points was able to be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="311">
                    <text>Since s1031 is a null allele, we have checked whether ligation of Lrp at the GATC1130 site can be altered by methylation of snails.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="312">
                    <text>Since s1031 is a null allele, we have checked whether ligation of Lrp at the GATC1130 site is altered by methylation of snails.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="313">
                    <text>Since s1031 is a null allele, we have checked whether ligation of Lrp at the GATC1130 site was able to be altered by methylation of snails.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="314">
                    <text>Since s1031 is a null allele, we have checked whether methylation of snails is altering ligation of Lrp at the GATC1130 site.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="315">
                    <text>Since s1031 is a null allele, we have checked whether mutations can alter cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="316">
                    <text>Since s1031 is a null allele, we have checked whether mutations has altered cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="317">
                    <text>Since s1031 is a null allele, we have checked whether mutations has altered cutoff points.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="318">
                    <text>Since s1031 is a null allele, we have checked whether mutations is altering coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="319">
                    <text>Since s1031 is a null allele, we have checked whether mutations is altering cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="320">
                    <text>Since s1031 is a null allele, we have checked whether mutations was able to alter coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="321">
                    <text>Since s1031 is a null allele, we have checked whether mutations was able to alter cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="322">
                    <text>Since s1031 is a null allele, we have checked whether mutations was able to alter spit sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="323">
                    <text>Since s1031 is a null allele, we have checked whether mutations would alter coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="324">
                    <text>Since s1031 is a null allele, we have checked whether phosphorylation of PDK1 is altered by treating cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="325">
                    <text>Since s1031 is a null allele, we have checked whether place of stacking was able to be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="326">
                    <text>Since s1031 is a null allele, we have checked whether protein product is altered by coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="327">
                    <text>Since s1031 is a null allele, we have checked whether spinning sites is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="328">
                    <text>Since s1031 is a null allele, we have checked whether spit sites can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="329">
                    <text>Since s1031 is a null allele, we have checked whether splicing can be altered by the molecular injury associated with s1031.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="330">
                    <text>Since s1031 is a null allele, we have checked whether the binding phase of the binding sites can be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="331">
                    <text>Since s1031 is a null allele, we have checked whether the phase of binding of the binding sites was altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="332">
                    <text>Since s1031 is a null allele, we have checked whether the phase of the bonding sites can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="333">
                    <text>Since s1031 is a null allele, we have checked whether the protein product can be altered by coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="334">
                    <text>Since s1031 is a null allele, we have checked whether treat cells with a growth factor similar to insulin-I has altered phosphorylation with PPDK1.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="335">
                    <text>Since s1031 is a null allele, we have checked whether treating cells with a growth factor similar to insulin-I can alter phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="336">
                    <text>Since s1031 is a null allele, we have checked whether treating cells with a growth factor similar to insulin-I is altering PDK1 phosphorylation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="337">
                    <text>Since s1031 is a null allele, we have checked whether treating cells with a growth factor similar to insulin-I is altering phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="338">
                    <text>Since s1031 is a null allele, we have checked whether treating cells with a growth factor similar to insulin-I was able to alter PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="339">
                    <text>Since s1031 is a null allele, we have checked whether treatment of cells with a growth factor similar to insulin-I can alter phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="340">
                    <text>Since s1031 is a null allele, we have checked whether treatment of cells with a growth factor similar to insulin-I has altered phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="341">
                    <text>Since s1031 is a null allele, we have checked whether treatment of cells with a growth factor similar to insulin-I was able to alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="342">
                    <text>Since s1031 is a null allele, we have checked whether treatment of cells with insulin-like growth factor I has altered PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="343">
                    <text>Since s1031 is a null allele, we have checked whether treatment of cells with insulin-like growth factor I is altering PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="344">
                    <text>Since s1031 is a null allele, we have checked whether treatment of cells with insulin-like growth factor I would alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="345">
                    <text>Since s1031 is a null allele, we tested whether a mechanism was able to alter Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="346">
                    <text>Since s1031 is a null allele, we tested whether cut-places was able to be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="347">
                    <text>Since s1031 is a null allele, we tested whether cut-variants is able to alter protein product.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="348">
                    <text>Since s1031 is a null allele, we tested whether ligation of Lrp at the GATC1130 site was able to be altered by methylation of snails.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="349">
                    <text>Since s1031 is a null allele, we tested whether methylation of prey was able to alter Lrp binding to the GATC1130 site.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="350">
                    <text>Since s1031 is a null allele, we tested whether methylation of snails is able to alter ligation of Lrp at the GATC1130 site.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="351">
                    <text>Since s1031 is a null allele, we tested whether mutations is able to alter spit sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="352">
                    <text>Since s1031 is a null allele, we tested whether protein product was able to be altered by coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="353">
                    <text>Since s1031 is a null allele, we tested whether spill sites was able to be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="354">
                    <text>Since s1031 is a null allele, we tested whether spit sites is able to be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="355">
                    <text>Since s1031 is a null allele, we tested whether the general direction of DNA is able to be altered by these two trunks.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="356">
                    <text>Since s1031 is a null allele, we tested whether the molecular injury associated with s1031 was able to alter splicing.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="357">
                    <text>Since s1031 is a null allele, we tested whether the phase of the bonding sites is able to be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="358">
                    <text>Since s1031 is a null allele, we tested whether treating cells with a growth factor similar to insulin-I is able to alter PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="359">
                    <text>Since the molecular injury associated with s1031 were in opposite directions, they altered no splicing(Figure 3C).</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="360">
                    <text>Since these two curves are in opposite directions, the general direction of the DNA will be altered by not by them (Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="361">
                    <text>Since these two curves are in opposite directions, they are not capable of altering the general direction of the DNA(Figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="362">
                    <text>Since these two curves are in opposite directions, they will alter no the general direction of the DNA (figure 3C).</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="363">
                    <text>Since these two trunks were in opposite directions, they were not capable of altering the general direction of DNA (figure 3C).</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="364">
                    <text>Since treat cells with a growth factor similar to insulin-I are in opposite directions, they are not capable of altering phosphorylation with PPDK1(Figure 3C).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="365">
                    <text>Since treating cells with a growth factor similar to insulin-I are in opposite directions, they are not capable of altering PDK1 phosphatation(Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="366">
                    <text>Since treating cells with a growth factor similar to insulin-I were in opposite directions, they altered no phosphorylation of PDK1(Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="367">
                    <text>Since treating cells with a growth factor similar to insulin-I were in opposite directions, they were not capable of altering PDK1 phosphatation (figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="368">
                    <text>Since treating cells with a growth factor similar to insulin-I were in opposite directions, they were not capable of altering PDK1 phosphatation(Figure 3C).</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="369">
                    <text>Since treatment of cells with a growth factor similar to insulin-I are in opposite directions, PDK1 phosphorylation will be altered by not by them (Figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="370">
                    <text>Since treatment of cells with a growth factor similar to insulin-I were in opposite directions, they were not capable of altering PDK1 phosphorylation (figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="371">
                    <text>Since treatment of cells with a growth factor similar to insulin-I were in opposite directions, they were not capable of altering phosphorylation with PPDK1(Figure 3C).</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="372">
                    <text>Since treatment of cells with insulin-like growth factor I are in opposite directions, they will alter no PDK1 phosphorylation (figure 3C).</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="373">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to Mutations, which has been able to suddenly alter the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="374">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to a mechanism, which has been able to suddenly alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="375">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to cut-variants, which has been able to suddenly alter protein product.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="376">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which has been able to suddenly alter spinning sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="377">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to treating cells with a growth factor similar to insulin-I, which has been able to suddenly alter PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="378">
                    <text>Therefore, Glu13 indirectly affects the specificity of DNA binding, probably due to treatment of cells with insulin-like growth factor I, which has been able to suddenly alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="379">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to a mechanism, which can subtly alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="380">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to cell treatment with a growth factor similar to insulin - I, which is able to subtly alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="381">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to cell treatment with insulin-I growth factor, which was able to subtly alter PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="382">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to methylation of prey, which can be able to subtly alter Lrp binding to the GATC1130 site.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="383">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to mutations, which can be able to subtly alter cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="384">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to mutations, which can be able to subtly alter place of stacking.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="385">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to mutations, which can be able to subtly alter spill sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="386">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to mutations, which is able to subtly alter coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="387">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to mutations, which is able to subtly alter cut place.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="388">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to mutations, which is able to subtly alter spit sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="389">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to mutations, which is able to subtly alter the phase of the bonding sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="390">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to treating cells with a growth factor similar to insulin-I, which can be able to subtly alter PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="391">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to treating cells with a growth factor similar to insulin-I, which was able to subtly alter PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="392">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to treatment of cells with a growth factor similar to insulin-I, which can subtly alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="393">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to treatment of cells with a growth factor similar to insulin-I, which is able to subtly alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="394">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to treatment of cells with a growth factor similar to insulin-I, which was able to subtly alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="395">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to treatment of cells with insulin-like growth factor I, which can subtly alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="396">
                    <text>Thus, Glu13 indirectly affects DNA binding specificity probably due to treatment of cells with insulin-like growth factor I, which was able to subtly alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="397">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to Mutations, which subtly altered the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="398">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to mutations, which subtly altered coupling site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="399">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to mutations, which subtly altered cutoff points.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="400">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to mutations, which subtly altered phase of the binding site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="401">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to mutations, which subtly altered spit sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="402">
                    <text>Thus, Glu13 indirectly affects the DNA binding specificity probably due to treating cells with a growth factor similar to insulin-I, which subtly altered PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="403">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as Bcl-3 are able to be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="404">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as PDK1 can be altered by cell treatment with a growth factor similar to insulin - I.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="405">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as PDK1 phosphorylation are able to be altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="406">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as cut-places can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="407">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as ligation of Lrp at the GATC1130 site are able to be altered by methylation of snails.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="408">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as phosphorylation with PPDK1 can be altered by treat cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="409">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as spinning sites can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="410">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, as the phase of the bonding sites can be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="411">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because Mutations can be able to subtly alter the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="412">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because Mutations is able to suddenly alter the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="413">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because Mutations may suddenly alter the phase of binding of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phase of binding of the binding sites</arg>
                </example>
                <example src="REPLACE" no="414">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because Mutations subtly alters the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="415">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a mechanism can be able to subtly alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="416">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a mechanism can subtly alter Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3</arg>
                </example>
                <example src="REPLACE" no="417">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because a mechanism subtly altered Bcl-3 expression.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">Bcl-3 expression</arg>
                </example>
                <example src="REPLACE" no="418">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with a growth factor similar to insulin - I is able to subtly alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="419">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with a growth factor similar to insulin - I is able to suddenly alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="420">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with a growth factor similar to insulin - I may suddenly alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="421">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with insulin-I growth factor can subtly alter PDK1 phosphorylation.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="422">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with insulin-I growth factor is able to subtly alter PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="423">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with insulin-I growth factor subtly altered PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="424">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with insulin-I growth factor suddenly altered PDK1 phosphorylation.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="425">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cell treatment with insulin-I growth factor suddenly alters PDK1 phosphorylation.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="426">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because coupling variants may suddenly alter protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="427">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because coupling variants subtly altered the protein product.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="428">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because cut-variants subtly alters protein product.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="429">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because docking variants can subtly alter the protein product.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="430">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because docking variants subtly altered the protein product.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="431">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because docking variants suddenly alters the protein product.</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="432">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because methylation of prey is able to subtly alter Lrp binding to the GATC1130 site.</text>
                    <arg n="0">methylation of prey</arg>
                    <arg n="1">Lrp binding to the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="433">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because methylation of snails is able to suddenly alter ligation of Lrp at the GATC1130 site.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="434">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because methylation of snails may suddenly alter ligation of Lrp at the GATC1130 site.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="435">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations can be able to subtly alter coupling sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="436">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations can subtly alter place of stacking.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="437">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations is able to suddenly alter cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="438">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations is able to suddenly alter spill sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="439">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations may be able to suddenly alter place of stacking.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="440">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations may be able to suddenly alter spinning sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="441">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations may be able to suddenly alter the phase of the bonding sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="442">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations subtly altered coupling site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="443">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations subtly altered cutoff points.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="444">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations subtly altered phase of the binding site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="445">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations subtly alters cut-places.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="446">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations subtly alters place of stacking.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="447">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations suddenly altered spit sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="448">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because mutations suddenly alters spit sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="449">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because slice variations suddenly alters protein product.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="450">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the molecular injury associated with s1031 subtly altered splicing.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="451">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because the molecular injury associated with s1031 subtly alters splicing.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="452">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two curves is able to suddenly alter the general direction of the DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="453">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two curves may suddenly alter the general direction of the DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="454">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two trunks can be able to subtly alter the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="455">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because these two trunks suddenly altered the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="456">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treat cells with a growth factor similar to insulin-I subtly alters PDK1 phosphorylation.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="457">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treat cells with a growth factor similar to insulin-I suddenly altered PDK1 phosphorylation.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="458">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I is able to subtly alter PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="459">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I is able to suddenly alter phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="460">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I subtly altered PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="461">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I subtly altered phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="462">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I subtly alters PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="463">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I subtly alters PDK1 phosphorylation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="464">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treating cells with a growth factor similar to insulin-I suddenly alters phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="465">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with a growth factor similar to insulin-I may suddenly alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="466">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with a growth factor similar to insulin-I subtly alters phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="467">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with a growth factor similar to insulin-I suddenly alters phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="468">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably because treatment of cells with insulin-like growth factor I subtly alters PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="469">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to Mutations, which suddenly altered the binding phase of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="470">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to cell treatment with a growth factor similar to insulin I, which is able to suddenly alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="471">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to cell treatment with a growth factor similar to insulin I, which may be able to suddenly alter PDK1.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="472">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to cell treatment with insulin-I growth factor, which may be able to suddenly alter phosphorylation of PDK1.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="473">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to cut-variants, which can suddenly alter protein product.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="474">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which is able to suddenly alter the phase of the bonding sites.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="475">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to mutations, which may be able to suddenly alter coupling site.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling site</arg>
                </example>
                <example src="REPLACE" no="476">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to slice variations, which may be able to suddenly alter protein product.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="477">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two curves, which is able to suddenly alter the general direction of the DNA.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="478">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to these two trunks, which suddenly altered the general direction of DNA.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="479">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to treat cells with a growth factor similar to insulin-I, which can suddenly alter PDK1 phosphorylation.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="480">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to treating cells with a growth factor similar to insulin-I, which can suddenly alter phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="481">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to treating cells with a growth factor similar to insulin-I, which is able to suddenly alter PDK1 phosphatation.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="482">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to treating cells with a growth factor similar to insulin-I, which suddenly altered phosphorylation of PDK1.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="483">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to treatment of cells with a growth factor similar to insulin-I, which is able to suddenly alter PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="484">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to treatment of cells with a growth factor similar to insulin-I, which suddenly altered phosphorylation with PPDK1.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="485">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, probably due to treatment of cells with insulin-like growth factor I, which suddenly altered PDK1 phosphorylation.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="486">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since PDK1 is altered by cell treatment with insulin-I growth factor.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="487">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since PDK1 was altered by cells treated with an insulin-like growth factor I.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="488">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since cut-places is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="489">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since cutoff points was altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="490">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since phosphorylation with PPDK1 is altered by treat cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="491">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since place of stacking is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="492">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since place of stacking was altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="493">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since spill sites was altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="494">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since spinning sites could be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="495">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since spinning sites was altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="496">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since splicing is altered by the molecular injury associated with s1031.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="497">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since splicing was altered by the molecular injury associated with s1031.</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="498">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the binding phase of the binding sites was altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="499">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the general direction of DNA could be altered by these two trunks.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="500">
                    <text>Thus, Glu13 indirectly affects the specificity of DNA binding, since the protein product can be altered by coupling variants.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="501">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since PDK1 phosphorylation is altered by treatment of cells with insulin-like growth factor I.</text>
                    <arg n="0">treatment of cells with insulin-like growth factor I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="502">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since coupling sites is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="503">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since phosphorylation with PPDK1 is altered by treatment of cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treatment of cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="504">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since phosphorylation with PPDK1 may be altered by treat cells with a growth factor similar to insulin-I.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation with PPDK1</arg>
                </example>
                <example src="REPLACE" no="505">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since place of stacking is altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">place of stacking</arg>
                </example>
                <example src="REPLACE" no="506">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the general direction of the DNA is altered by these two curves.</text>
                    <arg n="0">these two curves</arg>
                    <arg n="1">the general direction of the DNA</arg>
                </example>
                <example src="REPLACE" no="507">
                    <text>Thus, Glu13 indirectly affects the specificity of the DNA binding, since the phase of the bonding sites may be altered by mutations.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="508">
                    <text>We believe that Mutations is capable of altering the binding phase of the binding sites, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="509">
                    <text>We believe that cell treatment with a growth factor similar to insulin - I is capable of altering PDK1, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin - I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="510">
                    <text>We believe that cell treatment with a growth factor similar to insulin I is able to alter PDK1, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">cell treatment with a growth factor similar to insulin I</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="511">
                    <text>We believe that cell treatment with insulin-I growth factor is capable of altering PDK1 phosphorylation, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="512">
                    <text>We believe that mutations is capable of altering spit sites, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="513">
                    <text>We believe that mutations is capable of altering the phase of the bonding sites, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="514">
                    <text>We believe that these two trunks is able to alter the general direction of DNA, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="515">
                    <text>We believe that treating cells with a growth factor similar to insulin-I is capable of altering PDK1 phosphatation, we observe the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphatation</arg>
                </example>
                <example src="REPLACE" no="516">
                    <text>a mechanism is located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in variant genes.</text>
                    <arg n="0">a mechanism</arg>
                </example>
                <example src="REPLACE" no="517">
                    <text>cell treatment with insulin-I growth factor is predicted to alter PDK1 , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">cell treatment with insulin-I growth factor</arg>
                    <arg n="1">PDK1</arg>
                </example>
                <example src="REPLACE" no="518">
                    <text>cells treated with an insulin-like growth factor I is a predictor of A1 alteration (spacing), and the sos-1 RNA produced in this mutant was alter.</text>
                    <arg n="0">cells treated with an insulin-like growth factor I</arg>
                </example>
                <example src="REPLACE" no="519">
                    <text>coupling sites can be altered by mutations in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="520">
                    <text>coupling sites will be altered by mutations, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">coupling sites</arg>
                </example>
                <example src="REPLACE" no="521">
                    <text>coupling variants was able to alter the protein product in the A4 gene (DRI).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="522">
                    <text>cut place may be altered by mutations in the A4 gene (DVI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="523">
                    <text>cut place was altered by mutations in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="524">
                    <text>cutoff points may be altered by mutations in the A4 gene (DVI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="525">
                    <text>docking variants was able to alter the protein product in the A4 gene (DRI).</text>
                    <arg n="0">docking variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="526">
                    <text>ligation of Lrp at the GATC1130 site will be altered by methylation of snails, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">methylation of snails</arg>
                    <arg n="1">ligation of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="527">
                    <text>methylation of prey is located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in variant genes.</text>
                    <arg n="0">methylation of prey</arg>
                </example>
                <example src="REPLACE" no="528">
                    <text>methylation of snails was located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in the variant genes.</text>
                    <arg n="0">methylation of snails</arg>
                </example>
                <example src="REPLACE" no="529">
                    <text>mutations can alter cutoff points in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cutoff points</arg>
                </example>
                <example src="REPLACE" no="530">
                    <text>mutations can alter the phase of the bonding sites in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="531">
                    <text>mutations is predicted to alter cut-places , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut-places</arg>
                </example>
                <example src="REPLACE" no="532">
                    <text>mutations is predicted to alter phase of the binding site , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="533">
                    <text>mutations was able to alter cut place in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">cut place</arg>
                </example>
                <example src="REPLACE" no="534">
                    <text>mutations was able to alter spill sites in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="535">
                    <text>phase of the binding site will be altered by mutations, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">phase of the binding site</arg>
                </example>
                <example src="REPLACE" no="536">
                    <text>phosphorylation of PDK1 will be altered by treating cells with a growth factor similar to insulin-I, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">treating cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="537">
                    <text>prey methylation is located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in variant genes.</text>
                    <arg n="0">prey methylation</arg>
                </example>
                <example src="REPLACE" no="538">
                    <text>protein product will be altered by cut-variants, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">cut-variants</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="539">
                    <text>slice variations is located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in variant genes.</text>
                    <arg n="0">slice variations</arg>
                </example>
                <example src="REPLACE" no="540">
                    <text>slice variations made M-NEG (did not alter protein product and four of the sites could change without loss of activity.</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="541">
                    <text>slice variations was able to alter protein product in the A4 gene (DRI).</text>
                    <arg n="0">slice variations</arg>
                    <arg n="1">protein product</arg>
                </example>
                <example src="REPLACE" no="542">
                    <text>slice variations was located in the exon 2 and A1 altered (codon) (CTC) normally associated with Leu-93 in the transcortinal A2 polypeptide (to a codon) to histidine in the variant genes.</text>
                    <arg n="0">slice variations</arg>
                </example>
                <example src="REPLACE" no="543">
                    <text>spill sites will be altered by mutations, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spill sites</arg>
                </example>
                <example src="REPLACE" no="544">
                    <text>spinning sites is altered by mutations in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spinning sites</arg>
                </example>
                <example src="REPLACE" no="545">
                    <text>spit sites will be altered by mutations, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">spit sites</arg>
                </example>
                <example src="REPLACE" no="546">
                    <text>splicing may be altered by the molecular injury associated with s1031 in the A4 gene (DVI).</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="547">
                    <text>splicing was altered by the molecular injury associated with s1031 in the A4 gene (DRI).</text>
                    <arg n="0">the molecular injury associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="548">
                    <text>the binding phase of the binding sites is altered by Mutations in the A4 gene (DRI).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the binding phase of the binding sites</arg>
                </example>
                <example src="REPLACE" no="549">
                    <text>the general direction of DNA can be altered by these two trunks in the A4 gene (DRI).</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="550">
                    <text>the phase of the bonding sites can be altered by mutations in the A4 gene (DRI).</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">the phase of the bonding sites</arg>
                </example>
                <example src="REPLACE" no="551">
                    <text>the protein product is altered by coupling variants in the A4 gene (DRI).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="552">
                    <text>the protein product may be altered by coupling variants in the A4 gene (DVI).</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="553">
                    <text>the protein product will be altered by coupling variants, we look at the sos-1 RNA produced in this mutant.</text>
                    <arg n="0">coupling variants</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="554">
                    <text>these two curves is a predictor of A1 alteration (spacing), and the sos-1 RNA produced in this mutant was alter.</text>
                    <arg n="0">these two curves</arg>
                </example>
                <example src="REPLACE" no="555">
                    <text>these two trunks can alter the general direction of DNA in the A4 gene (DRI).</text>
                    <arg n="0">these two trunks</arg>
                    <arg n="1">the general direction of DNA</arg>
                </example>
                <example src="REPLACE" no="556">
                    <text>treat cells with a growth factor similar to insulin-I is predicted to alter PDK1 phosphorylation , the sos-1 mRNA produced in this mutant was observed.</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
                <example src="REPLACE" no="557">
                    <text>treat cells with a growth factor similar to insulin-I was able to alter PDK1 phosphorylation in the A4 gene (DRI).</text>
                    <arg n="0">treat cells with a growth factor similar to insulin-I</arg>
                    <arg n="1">PDK1 phosphorylation</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
